{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "import threading\n",
    "import time\n",
    "import openai\n",
    "from threading import Lock\n",
    "from langchain_community.embeddings import OpenAIEmbeddings\n",
    "# from langchain_openai import OpenAIEmbeddings\n",
    "from dotenv import load_dotenv\n",
    "load_dotenv()\n",
    "import json\n",
    "from langchain_community.vectorstores import Chroma\n",
    "import pandas as pd\n",
    "import sys"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'c:\\\\Users\\\\Pyrack\\\\Desktop\\\\dorisjv\\\\dorisclinicaltrials\\\\Notebooks'"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv(\"FinalCTTrialsDF_Full_w_ContactInfo_LocList_testing.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_1 = pd.read_csv(\"FinalCTTrialsDF_P1_w_ContactInfo_LocList.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0.3</th>\n",
       "      <th>Unnamed: 0.2</th>\n",
       "      <th>Unnamed: 0.1</th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>NCT_NUMBER</th>\n",
       "      <th>STUDY_TITLE</th>\n",
       "      <th>STUDY_URL</th>\n",
       "      <th>STUDY_STATUS</th>\n",
       "      <th>CONDITIONS</th>\n",
       "      <th>START_DATE</th>\n",
       "      <th>COMPLETION_DATE</th>\n",
       "      <th>AGE</th>\n",
       "      <th>ELIGIBILITY_CRITERIA</th>\n",
       "      <th>PRIMARY_OUTCOMES</th>\n",
       "      <th>SECONDARY_OUTCOMES</th>\n",
       "      <th>INTERVENTIONS</th>\n",
       "      <th>POINT_OF_CONTACT</th>\n",
       "      <th>LOCATIONS</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NCT03275311</td>\n",
       "      <td>Evolution of the Therapeutic Care in Metastati...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03275311</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Metastatic Breast Cancer</td>\n",
       "      <td>July 2014</td>\n",
       "      <td>December 2024</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients 18 years or olde...</td>\n",
       "      <td>The primary outcome measure is to describe the...</td>\n",
       "      <td>Secondary outcomes focus on the impact of ther...</td>\n",
       "      <td>The study does not specify particular interven...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>[{'Location Facility': \"Institut de Cancérolog...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>20</td>\n",
       "      <td>20</td>\n",
       "      <td>20</td>\n",
       "      <td>20</td>\n",
       "      <td>NCT06145399</td>\n",
       "      <td>A Study of 1 8F-FDHT PET/MRIScans in Women Wit...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06145399</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer, Breast Carcinoma, Metastatic Br...</td>\n",
       "      <td>October 24, 2023</td>\n",
       "      <td>October 24, 2026</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals aged ≥ 18 yea...</td>\n",
       "      <td>The primary outcome is to correlate 18F-FDHT u...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>Participants with histologically confirmed AR+...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>[{'Location Facility': 'Memorial Sloan Ketteri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>21</td>\n",
       "      <td>21</td>\n",
       "      <td>21</td>\n",
       "      <td>21</td>\n",
       "      <td>NCT05496101</td>\n",
       "      <td>CLI and FAR for Intraoperative Margin Assessment</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05496101</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer Female</td>\n",
       "      <td>November 21, 2022</td>\n",
       "      <td>December 31, 2024</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes female subjects ≥18 years...</td>\n",
       "      <td>The primary outcome focuses on the margin stat...</td>\n",
       "      <td>Secondary outcomes include the agreement betwe...</td>\n",
       "      <td>The intervention involves the use of the Light...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>[{'Location Facility': \"Guy's and St Thomas NH...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>22</td>\n",
       "      <td>22</td>\n",
       "      <td>22</td>\n",
       "      <td>22</td>\n",
       "      <td>NCT05935384</td>\n",
       "      <td>SIBYL: obServation of Therapy Response With lI...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05935384</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Non-small Cell Lung Cancer, Colorectal Cancer,...</td>\n",
       "      <td>October 25, 2023</td>\n",
       "      <td>August 30, 2029</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients treated with fir...</td>\n",
       "      <td>The primary outcome is the sensitivity of circ...</td>\n",
       "      <td>Secondary outcomes include RECIST v1.1 respons...</td>\n",
       "      <td>The intervention involves the Guardant360 diag...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>[{'Location Facility': 'Orchard Healthcare Res...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>23</td>\n",
       "      <td>23</td>\n",
       "      <td>23</td>\n",
       "      <td>23</td>\n",
       "      <td>NCT05281237</td>\n",
       "      <td>Avecure Flexible Microwave Ablation Probe For ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05281237</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Stage I - II Primary Lung Cancer, Stage I Lung...</td>\n",
       "      <td>June 1, 2022</td>\n",
       "      <td>June 30, 2025</td>\n",
       "      <td>22 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals with Stage I ...</td>\n",
       "      <td>The primary outcomes focus on the feasibility ...</td>\n",
       "      <td>Secondary outcomes involve examining histologi...</td>\n",
       "      <td>The intervention involves the use of the AveCu...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>[{'Location Facility': 'Beth Israel Deaconess ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1095</th>\n",
       "      <td>17887</td>\n",
       "      <td>17887</td>\n",
       "      <td>17887</td>\n",
       "      <td>17887</td>\n",
       "      <td>NCT05006131</td>\n",
       "      <td>Pancreatic Cancer Screening for At-risk Indivi...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05006131</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Pancreatic Cancer, Adult</td>\n",
       "      <td>July 10, 2020</td>\n",
       "      <td>July 10, 2026</td>\n",
       "      <td>18 Years|90 Years|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals indicated for...</td>\n",
       "      <td>The primary outcome is the proportion of scree...</td>\n",
       "      <td>Secondary outcomes include the proportion of s...</td>\n",
       "      <td>The intervention involves screening for pancre...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>[{'Location Facility': 'Beth Israel Deaconess ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1096</th>\n",
       "      <td>17888</td>\n",
       "      <td>17888</td>\n",
       "      <td>17888</td>\n",
       "      <td>17888</td>\n",
       "      <td>NCT04679064</td>\n",
       "      <td>Trial on NIraparib-TSR-042 (Dostarlimab) vs Ph...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04679064</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Ovarian Cancer</td>\n",
       "      <td>December 1, 2020</td>\n",
       "      <td>January 1, 2025</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes recurrent ovarian, Fallop...</td>\n",
       "      <td>The primary outcome measure is overall surviva...</td>\n",
       "      <td>Secondary outcomes include progression-free su...</td>\n",
       "      <td>Interventions include a choice of standard che...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>[{'Location Facility': 'Azienda Ospedaliera Sp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1097</th>\n",
       "      <td>17896</td>\n",
       "      <td>17896</td>\n",
       "      <td>17896</td>\n",
       "      <td>17896</td>\n",
       "      <td>NCT04491864</td>\n",
       "      <td>DWIBS-MRI: An Adjunct to the Traditional Diagn...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04491864</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>March 11, 2019</td>\n",
       "      <td>March 11, 2024</td>\n",
       "      <td>30 Years||Adult|Older Adult</td>\n",
       "      <td>Eligible participants are genetic females over...</td>\n",
       "      <td>The study aims to assess the accuracy of MRI D...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>The document does not specify interventions, f...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>[{'Location Facility': 'Baylor Scott &amp; White R...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1098</th>\n",
       "      <td>17897</td>\n",
       "      <td>17897</td>\n",
       "      <td>17897</td>\n",
       "      <td>17897</td>\n",
       "      <td>NCT05905939</td>\n",
       "      <td>HER2(Human Epidermal Growth Factor Receptor 2)...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05905939</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>May 31, 2023</td>\n",
       "      <td>May 31, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with HER2-positi...</td>\n",
       "      <td>The primary outcomes aim to describe the clini...</td>\n",
       "      <td>Secondary outcomes focus on describing diagnos...</td>\n",
       "      <td>The study does not specify interventions, as i...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>[{'Location Facility': 'Research Site', 'Locat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1099</th>\n",
       "      <td>17930</td>\n",
       "      <td>17930</td>\n",
       "      <td>17930</td>\n",
       "      <td>17930</td>\n",
       "      <td>NCT03934905</td>\n",
       "      <td>Protective Effects of the Nutritional Suppleme...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03934905</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Anthracycline Related Cardiotoxicity in Breast...</td>\n",
       "      <td>June 1, 2022</td>\n",
       "      <td>June 1, 2026</td>\n",
       "      <td>18 Years|89 Years|Adult|Older Adult</td>\n",
       "      <td>Participants aged 18 to 89, without prior diag...</td>\n",
       "      <td>The primary outcome is the change in cardiac f...</td>\n",
       "      <td>Secondary outcomes include monitoring troponin...</td>\n",
       "      <td>Participants will receive either sulforaphane ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>[{'Location Facility': 'Texas Tech University ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1100 rows × 18 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0.3  Unnamed: 0.2  Unnamed: 0.1  Unnamed: 0   NCT_NUMBER  \\\n",
       "0                0             0             0           0  NCT03275311   \n",
       "1               20            20            20          20  NCT06145399   \n",
       "2               21            21            21          21  NCT05496101   \n",
       "3               22            22            22          22  NCT05935384   \n",
       "4               23            23            23          23  NCT05281237   \n",
       "...            ...           ...           ...         ...          ...   \n",
       "1095         17887         17887         17887       17887  NCT05006131   \n",
       "1096         17888         17888         17888       17888  NCT04679064   \n",
       "1097         17896         17896         17896       17896  NCT04491864   \n",
       "1098         17897         17897         17897       17897  NCT05905939   \n",
       "1099         17930         17930         17930       17930  NCT03934905   \n",
       "\n",
       "                                            STUDY_TITLE  \\\n",
       "0     Evolution of the Therapeutic Care in Metastati...   \n",
       "1     A Study of 1 8F-FDHT PET/MRIScans in Women Wit...   \n",
       "2      CLI and FAR for Intraoperative Margin Assessment   \n",
       "3     SIBYL: obServation of Therapy Response With lI...   \n",
       "4     Avecure Flexible Microwave Ablation Probe For ...   \n",
       "...                                                 ...   \n",
       "1095  Pancreatic Cancer Screening for At-risk Indivi...   \n",
       "1096  Trial on NIraparib-TSR-042 (Dostarlimab) vs Ph...   \n",
       "1097  DWIBS-MRI: An Adjunct to the Traditional Diagn...   \n",
       "1098  HER2(Human Epidermal Growth Factor Receptor 2)...   \n",
       "1099  Protective Effects of the Nutritional Suppleme...   \n",
       "\n",
       "                                             STUDY_URL STUDY_STATUS  \\\n",
       "0     https://www.clinicaltrials.gov/study/NCT03275311   Recruiting   \n",
       "1     https://www.clinicaltrials.gov/study/NCT06145399   Recruiting   \n",
       "2     https://www.clinicaltrials.gov/study/NCT05496101   Recruiting   \n",
       "3     https://www.clinicaltrials.gov/study/NCT05935384   Recruiting   \n",
       "4     https://www.clinicaltrials.gov/study/NCT05281237   Recruiting   \n",
       "...                                                ...          ...   \n",
       "1095  https://www.clinicaltrials.gov/study/NCT05006131   Recruiting   \n",
       "1096  https://www.clinicaltrials.gov/study/NCT04679064   Recruiting   \n",
       "1097  https://www.clinicaltrials.gov/study/NCT04491864   Recruiting   \n",
       "1098  https://www.clinicaltrials.gov/study/NCT05905939   Recruiting   \n",
       "1099  https://www.clinicaltrials.gov/study/NCT03934905   Recruiting   \n",
       "\n",
       "                                             CONDITIONS         START_DATE  \\\n",
       "0                              Metastatic Breast Cancer          July 2014   \n",
       "1     Breast Cancer, Breast Carcinoma, Metastatic Br...   October 24, 2023   \n",
       "2                                  Breast Cancer Female  November 21, 2022   \n",
       "3     Non-small Cell Lung Cancer, Colorectal Cancer,...   October 25, 2023   \n",
       "4     Stage I - II Primary Lung Cancer, Stage I Lung...       June 1, 2022   \n",
       "...                                                 ...                ...   \n",
       "1095                           Pancreatic Cancer, Adult      July 10, 2020   \n",
       "1096                                     Ovarian Cancer   December 1, 2020   \n",
       "1097                                      Breast Cancer     March 11, 2019   \n",
       "1098                                      Breast Cancer       May 31, 2023   \n",
       "1099  Anthracycline Related Cardiotoxicity in Breast...       June 1, 2022   \n",
       "\n",
       "        COMPLETION_DATE                                  AGE  \\\n",
       "0         December 2024          18 Years||Adult|Older Adult   \n",
       "1      October 24, 2026          18 Years||Adult|Older Adult   \n",
       "2     December 31, 2024          18 Years||Adult|Older Adult   \n",
       "3       August 30, 2029          18 Years||Adult|Older Adult   \n",
       "4         June 30, 2025          22 Years||Adult|Older Adult   \n",
       "...                 ...                                  ...   \n",
       "1095      July 10, 2026  18 Years|90 Years|Adult|Older Adult   \n",
       "1096    January 1, 2025          18 Years||Adult|Older Adult   \n",
       "1097     March 11, 2024          30 Years||Adult|Older Adult   \n",
       "1098       May 31, 2024            ||Child|Adult|Older Adult   \n",
       "1099       June 1, 2026  18 Years|89 Years|Adult|Older Adult   \n",
       "\n",
       "                                   ELIGIBILITY_CRITERIA  \\\n",
       "0     Eligibility includes patients 18 years or olde...   \n",
       "1     Eligibility includes individuals aged ≥ 18 yea...   \n",
       "2     Eligibility includes female subjects ≥18 years...   \n",
       "3     Eligibility includes patients treated with fir...   \n",
       "4     Eligibility includes individuals with Stage I ...   \n",
       "...                                                 ...   \n",
       "1095  Eligibility includes individuals indicated for...   \n",
       "1096  Eligibility includes recurrent ovarian, Fallop...   \n",
       "1097  Eligible participants are genetic females over...   \n",
       "1098  Eligibility includes patients with HER2-positi...   \n",
       "1099  Participants aged 18 to 89, without prior diag...   \n",
       "\n",
       "                                       PRIMARY_OUTCOMES  \\\n",
       "0     The primary outcome measure is to describe the...   \n",
       "1     The primary outcome is to correlate 18F-FDHT u...   \n",
       "2     The primary outcome focuses on the margin stat...   \n",
       "3     The primary outcome is the sensitivity of circ...   \n",
       "4     The primary outcomes focus on the feasibility ...   \n",
       "...                                                 ...   \n",
       "1095  The primary outcome is the proportion of scree...   \n",
       "1096  The primary outcome measure is overall surviva...   \n",
       "1097  The study aims to assess the accuracy of MRI D...   \n",
       "1098  The primary outcomes aim to describe the clini...   \n",
       "1099  The primary outcome is the change in cardiac f...   \n",
       "\n",
       "                                     SECONDARY_OUTCOMES  \\\n",
       "0     Secondary outcomes focus on the impact of ther...   \n",
       "1                  No secondary outcomes were provided.   \n",
       "2     Secondary outcomes include the agreement betwe...   \n",
       "3     Secondary outcomes include RECIST v1.1 respons...   \n",
       "4     Secondary outcomes involve examining histologi...   \n",
       "...                                                 ...   \n",
       "1095  Secondary outcomes include the proportion of s...   \n",
       "1096  Secondary outcomes include progression-free su...   \n",
       "1097               No secondary outcomes were provided.   \n",
       "1098  Secondary outcomes focus on describing diagnos...   \n",
       "1099  Secondary outcomes include monitoring troponin...   \n",
       "\n",
       "                                          INTERVENTIONS  \\\n",
       "0     The study does not specify particular interven...   \n",
       "1     Participants with histologically confirmed AR+...   \n",
       "2     The intervention involves the use of the Light...   \n",
       "3     The intervention involves the Guardant360 diag...   \n",
       "4     The intervention involves the use of the AveCu...   \n",
       "...                                                 ...   \n",
       "1095  The intervention involves screening for pancre...   \n",
       "1096  Interventions include a choice of standard che...   \n",
       "1097  The document does not specify interventions, f...   \n",
       "1098  The study does not specify interventions, as i...   \n",
       "1099  Participants will receive either sulforaphane ...   \n",
       "\n",
       "                                       POINT_OF_CONTACT  \\\n",
       "0     {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1     {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2     {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3     {'Name': None, 'Organization': None, 'Email': ...   \n",
       "4     {'Name': None, 'Organization': None, 'Email': ...   \n",
       "...                                                 ...   \n",
       "1095  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1096  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1097  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1098  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1099  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "\n",
       "                                              LOCATIONS  \n",
       "0     [{'Location Facility': \"Institut de Cancérolog...  \n",
       "1     [{'Location Facility': 'Memorial Sloan Ketteri...  \n",
       "2     [{'Location Facility': \"Guy's and St Thomas NH...  \n",
       "3     [{'Location Facility': 'Orchard Healthcare Res...  \n",
       "4     [{'Location Facility': 'Beth Israel Deaconess ...  \n",
       "...                                                 ...  \n",
       "1095  [{'Location Facility': 'Beth Israel Deaconess ...  \n",
       "1096  [{'Location Facility': 'Azienda Ospedaliera Sp...  \n",
       "1097  [{'Location Facility': 'Baylor Scott & White R...  \n",
       "1098  [{'Location Facility': 'Research Site', 'Locat...  \n",
       "1099  [{'Location Facility': 'Texas Tech University ...  \n",
       "\n",
       "[1100 rows x 18 columns]"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>NCT_NUMBER</th>\n",
       "      <th>STUDY_TITLE</th>\n",
       "      <th>STUDY_URL</th>\n",
       "      <th>STUDY_STATUS</th>\n",
       "      <th>CONDITIONS</th>\n",
       "      <th>LOCATIONS</th>\n",
       "      <th>START_DATE</th>\n",
       "      <th>COMPLETION_DATE</th>\n",
       "      <th>AGE</th>\n",
       "      <th>ELIGIBILITY_CRITERIA</th>\n",
       "      <th>PRIMARY_OUTCOMES</th>\n",
       "      <th>SECONDARY_OUTCOMES</th>\n",
       "      <th>INTERVENTIONS</th>\n",
       "      <th>POINT_OF_CONTACT</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>NCT05664971</td>\n",
       "      <td>JS004 Combined With Toripalimab and With Stand...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05664971</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Advanced Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'Shanghai Chest Hospita...</td>\n",
       "      <td>February 9, 2023</td>\n",
       "      <td>November 17, 2024</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligible participants include males or females...</td>\n",
       "      <td>The primary outcomes include the incidence of ...</td>\n",
       "      <td>Secondary outcomes encompass the duration of r...</td>\n",
       "      <td>The study involves multiple cohorts receiving ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT05902520</td>\n",
       "      <td>Adoptive Cell Therapy Using Cancer Specific CD...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05902520</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>HNSCC, Melanoma, Gynecologic Cancer, Colorecta...</td>\n",
       "      <td>[{'Location Facility': 'Providence Portland Me...</td>\n",
       "      <td>June 19, 2023</td>\n",
       "      <td>May 19, 2026</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes adults over 18 with histo...</td>\n",
       "      <td>The primary outcome is to assess the safety of...</td>\n",
       "      <td>Secondary outcomes include evaluating the effi...</td>\n",
       "      <td>The study involves two experimental arms. Both...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT03917043</td>\n",
       "      <td>APG-2449 in Patients With Advanced Solid Tumors</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03917043</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Advanced Solid Cancer, Non Small Cell Lung Can...</td>\n",
       "      <td>[{'Location Facility': 'Beijing Cancer Hospita...</td>\n",
       "      <td>May 27, 2019</td>\n",
       "      <td>February 2025</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with advanced tu...</td>\n",
       "      <td>The primary outcomes are to determine the maxi...</td>\n",
       "      <td>Secondary outcomes include measuring the maxim...</td>\n",
       "      <td>The intervention involves administering APG-24...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT05674422</td>\n",
       "      <td>GEMCAD-REVEAL STUDY - Circulating Tumor DNA as...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05674422</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Patients With Locally Advanced Rectal Cancer</td>\n",
       "      <td>[{'Location Facility': 'Hospital Germans Trias...</td>\n",
       "      <td>May 26, 2023</td>\n",
       "      <td>July 2026</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligible participants are legally capable indi...</td>\n",
       "      <td>The primary outcome measure is the detection o...</td>\n",
       "      <td>Secondary outcomes include the classification ...</td>\n",
       "      <td>The intervention involves total neoadjuvant th...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT06249854</td>\n",
       "      <td>Efficacy and Safety of Combination Therapy Wit...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06249854</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Non-small Cell Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'Korea University Ansan...</td>\n",
       "      <td>February 8, 2024</td>\n",
       "      <td>December 31, 2025</td>\n",
       "      <td>19 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes adults aged 19 or older w...</td>\n",
       "      <td>The primary outcome measure is Progression-Fre...</td>\n",
       "      <td>Secondary outcomes include Disease Control Rat...</td>\n",
       "      <td>The study involves two groups: one receiving P...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3831</th>\n",
       "      <td>3831</td>\n",
       "      <td>NCT05006131</td>\n",
       "      <td>Pancreatic Cancer Screening for At-risk Indivi...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05006131</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Pancreatic Cancer, Adult</td>\n",
       "      <td>[{'Location Facility': 'Beth Israel Deaconess ...</td>\n",
       "      <td>July 10, 2020</td>\n",
       "      <td>July 10, 2026</td>\n",
       "      <td>18 Years|90 Years|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals indicated for...</td>\n",
       "      <td>The primary outcome is the proportion of scree...</td>\n",
       "      <td>Secondary outcomes include the proportion of s...</td>\n",
       "      <td>The intervention involves screening for pancre...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3832</th>\n",
       "      <td>3832</td>\n",
       "      <td>NCT04679064</td>\n",
       "      <td>Trial on NIraparib-TSR-042 (Dostarlimab) vs Ph...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04679064</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Ovarian Cancer</td>\n",
       "      <td>[{'Location Facility': 'Azienda Ospedaliera Sp...</td>\n",
       "      <td>December 1, 2020</td>\n",
       "      <td>January 1, 2025</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes recurrent ovarian, Fallop...</td>\n",
       "      <td>The primary outcome measure is overall surviva...</td>\n",
       "      <td>Secondary outcomes include progression-free su...</td>\n",
       "      <td>Interventions include a choice of standard che...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3833</th>\n",
       "      <td>3833</td>\n",
       "      <td>NCT04491864</td>\n",
       "      <td>DWIBS-MRI: An Adjunct to the Traditional Diagn...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04491864</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Baylor Scott &amp; White R...</td>\n",
       "      <td>March 11, 2019</td>\n",
       "      <td>March 11, 2024</td>\n",
       "      <td>30 Years||Adult|Older Adult</td>\n",
       "      <td>Eligible participants are genetic females over...</td>\n",
       "      <td>The study aims to assess the accuracy of MRI D...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>The document does not specify interventions, f...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3834</th>\n",
       "      <td>3834</td>\n",
       "      <td>NCT05905939</td>\n",
       "      <td>HER2(Human Epidermal Growth Factor Receptor 2)...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05905939</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Research Site', 'Locat...</td>\n",
       "      <td>May 31, 2023</td>\n",
       "      <td>May 31, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with HER2-positi...</td>\n",
       "      <td>The primary outcomes aim to describe the clini...</td>\n",
       "      <td>Secondary outcomes focus on describing diagnos...</td>\n",
       "      <td>The study does not specify interventions, as i...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3835</th>\n",
       "      <td>3835</td>\n",
       "      <td>NCT03934905</td>\n",
       "      <td>Protective Effects of the Nutritional Suppleme...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03934905</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Anthracycline Related Cardiotoxicity in Breast...</td>\n",
       "      <td>[{'Location Facility': 'Texas Tech University ...</td>\n",
       "      <td>June 1, 2022</td>\n",
       "      <td>June 1, 2026</td>\n",
       "      <td>18 Years|89 Years|Adult|Older Adult</td>\n",
       "      <td>Participants aged 18 to 89, without prior diag...</td>\n",
       "      <td>The primary outcome is the change in cardiac f...</td>\n",
       "      <td>Secondary outcomes include monitoring troponin...</td>\n",
       "      <td>Participants will receive either sulforaphane ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3836 rows × 15 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0   NCT_NUMBER  \\\n",
       "0              0  NCT05664971   \n",
       "1              1  NCT05902520   \n",
       "2              2  NCT03917043   \n",
       "3              3  NCT05674422   \n",
       "4              4  NCT06249854   \n",
       "...          ...          ...   \n",
       "3831        3831  NCT05006131   \n",
       "3832        3832  NCT04679064   \n",
       "3833        3833  NCT04491864   \n",
       "3834        3834  NCT05905939   \n",
       "3835        3835  NCT03934905   \n",
       "\n",
       "                                            STUDY_TITLE  \\\n",
       "0     JS004 Combined With Toripalimab and With Stand...   \n",
       "1     Adoptive Cell Therapy Using Cancer Specific CD...   \n",
       "2       APG-2449 in Patients With Advanced Solid Tumors   \n",
       "3     GEMCAD-REVEAL STUDY - Circulating Tumor DNA as...   \n",
       "4     Efficacy and Safety of Combination Therapy Wit...   \n",
       "...                                                 ...   \n",
       "3831  Pancreatic Cancer Screening for At-risk Indivi...   \n",
       "3832  Trial on NIraparib-TSR-042 (Dostarlimab) vs Ph...   \n",
       "3833  DWIBS-MRI: An Adjunct to the Traditional Diagn...   \n",
       "3834  HER2(Human Epidermal Growth Factor Receptor 2)...   \n",
       "3835  Protective Effects of the Nutritional Suppleme...   \n",
       "\n",
       "                                             STUDY_URL STUDY_STATUS  \\\n",
       "0     https://www.clinicaltrials.gov/study/NCT05664971   Recruiting   \n",
       "1     https://www.clinicaltrials.gov/study/NCT05902520   Recruiting   \n",
       "2     https://www.clinicaltrials.gov/study/NCT03917043   Recruiting   \n",
       "3     https://www.clinicaltrials.gov/study/NCT05674422   Recruiting   \n",
       "4     https://www.clinicaltrials.gov/study/NCT06249854   Recruiting   \n",
       "...                                                ...          ...   \n",
       "3831  https://www.clinicaltrials.gov/study/NCT05006131   Recruiting   \n",
       "3832  https://www.clinicaltrials.gov/study/NCT04679064   Recruiting   \n",
       "3833  https://www.clinicaltrials.gov/study/NCT04491864   Recruiting   \n",
       "3834  https://www.clinicaltrials.gov/study/NCT05905939   Recruiting   \n",
       "3835  https://www.clinicaltrials.gov/study/NCT03934905   Recruiting   \n",
       "\n",
       "                                             CONDITIONS  \\\n",
       "0                                  Advanced Lung Cancer   \n",
       "1     HNSCC, Melanoma, Gynecologic Cancer, Colorecta...   \n",
       "2     Advanced Solid Cancer, Non Small Cell Lung Can...   \n",
       "3          Patients With Locally Advanced Rectal Cancer   \n",
       "4                            Non-small Cell Lung Cancer   \n",
       "...                                                 ...   \n",
       "3831                           Pancreatic Cancer, Adult   \n",
       "3832                                     Ovarian Cancer   \n",
       "3833                                      Breast Cancer   \n",
       "3834                                      Breast Cancer   \n",
       "3835  Anthracycline Related Cardiotoxicity in Breast...   \n",
       "\n",
       "                                              LOCATIONS        START_DATE  \\\n",
       "0     [{'Location Facility': 'Shanghai Chest Hospita...  February 9, 2023   \n",
       "1     [{'Location Facility': 'Providence Portland Me...     June 19, 2023   \n",
       "2     [{'Location Facility': 'Beijing Cancer Hospita...      May 27, 2019   \n",
       "3     [{'Location Facility': 'Hospital Germans Trias...      May 26, 2023   \n",
       "4     [{'Location Facility': 'Korea University Ansan...  February 8, 2024   \n",
       "...                                                 ...               ...   \n",
       "3831  [{'Location Facility': 'Beth Israel Deaconess ...     July 10, 2020   \n",
       "3832  [{'Location Facility': 'Azienda Ospedaliera Sp...  December 1, 2020   \n",
       "3833  [{'Location Facility': 'Baylor Scott & White R...    March 11, 2019   \n",
       "3834  [{'Location Facility': 'Research Site', 'Locat...      May 31, 2023   \n",
       "3835  [{'Location Facility': 'Texas Tech University ...      June 1, 2022   \n",
       "\n",
       "        COMPLETION_DATE                                  AGE  \\\n",
       "0     November 17, 2024          18 Years||Adult|Older Adult   \n",
       "1          May 19, 2026          18 Years||Adult|Older Adult   \n",
       "2         February 2025          18 Years||Adult|Older Adult   \n",
       "3             July 2026          18 Years||Adult|Older Adult   \n",
       "4     December 31, 2025          19 Years||Adult|Older Adult   \n",
       "...                 ...                                  ...   \n",
       "3831      July 10, 2026  18 Years|90 Years|Adult|Older Adult   \n",
       "3832    January 1, 2025          18 Years||Adult|Older Adult   \n",
       "3833     March 11, 2024          30 Years||Adult|Older Adult   \n",
       "3834       May 31, 2024            ||Child|Adult|Older Adult   \n",
       "3835       June 1, 2026  18 Years|89 Years|Adult|Older Adult   \n",
       "\n",
       "                                   ELIGIBILITY_CRITERIA  \\\n",
       "0     Eligible participants include males or females...   \n",
       "1     Eligibility includes adults over 18 with histo...   \n",
       "2     Eligibility includes patients with advanced tu...   \n",
       "3     Eligible participants are legally capable indi...   \n",
       "4     Eligibility includes adults aged 19 or older w...   \n",
       "...                                                 ...   \n",
       "3831  Eligibility includes individuals indicated for...   \n",
       "3832  Eligibility includes recurrent ovarian, Fallop...   \n",
       "3833  Eligible participants are genetic females over...   \n",
       "3834  Eligibility includes patients with HER2-positi...   \n",
       "3835  Participants aged 18 to 89, without prior diag...   \n",
       "\n",
       "                                       PRIMARY_OUTCOMES  \\\n",
       "0     The primary outcomes include the incidence of ...   \n",
       "1     The primary outcome is to assess the safety of...   \n",
       "2     The primary outcomes are to determine the maxi...   \n",
       "3     The primary outcome measure is the detection o...   \n",
       "4     The primary outcome measure is Progression-Fre...   \n",
       "...                                                 ...   \n",
       "3831  The primary outcome is the proportion of scree...   \n",
       "3832  The primary outcome measure is overall surviva...   \n",
       "3833  The study aims to assess the accuracy of MRI D...   \n",
       "3834  The primary outcomes aim to describe the clini...   \n",
       "3835  The primary outcome is the change in cardiac f...   \n",
       "\n",
       "                                     SECONDARY_OUTCOMES  \\\n",
       "0     Secondary outcomes encompass the duration of r...   \n",
       "1     Secondary outcomes include evaluating the effi...   \n",
       "2     Secondary outcomes include measuring the maxim...   \n",
       "3     Secondary outcomes include the classification ...   \n",
       "4     Secondary outcomes include Disease Control Rat...   \n",
       "...                                                 ...   \n",
       "3831  Secondary outcomes include the proportion of s...   \n",
       "3832  Secondary outcomes include progression-free su...   \n",
       "3833               No secondary outcomes were provided.   \n",
       "3834  Secondary outcomes focus on describing diagnos...   \n",
       "3835  Secondary outcomes include monitoring troponin...   \n",
       "\n",
       "                                          INTERVENTIONS  \\\n",
       "0     The study involves multiple cohorts receiving ...   \n",
       "1     The study involves two experimental arms. Both...   \n",
       "2     The intervention involves administering APG-24...   \n",
       "3     The intervention involves total neoadjuvant th...   \n",
       "4     The study involves two groups: one receiving P...   \n",
       "...                                                 ...   \n",
       "3831  The intervention involves screening for pancre...   \n",
       "3832  Interventions include a choice of standard che...   \n",
       "3833  The document does not specify interventions, f...   \n",
       "3834  The study does not specify interventions, as i...   \n",
       "3835  Participants will receive either sulforaphane ...   \n",
       "\n",
       "                                       POINT_OF_CONTACT  \n",
       "0     {'Name': None, 'Organization': None, 'Email': ...  \n",
       "1     {'Name': None, 'Organization': None, 'Email': ...  \n",
       "2     {'Name': None, 'Organization': None, 'Email': ...  \n",
       "3     {'Name': None, 'Organization': None, 'Email': ...  \n",
       "4     {'Name': None, 'Organization': None, 'Email': ...  \n",
       "...                                                 ...  \n",
       "3831  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "3832  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "3833  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "3834  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "3835  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "\n",
       "[3836 rows x 15 columns]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "lung_cancer_df = df[df['CONDITIONS'].str.contains('Lung Cancer', case=False)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Unnamed: 0', 'NCT_NUMBER', 'STUDY_TITLE', 'STUDY_URL', 'STUDY_STATUS',\n",
       "       'CONDITIONS', 'LOCATIONS', 'START_DATE', 'COMPLETION_DATE', 'AGE',\n",
       "       'ELIGIBILITY_CRITERIA', 'PRIMARY_OUTCOMES', 'SECONDARY_OUTCOMES',\n",
       "       'INTERVENTIONS', 'POINT_OF_CONTACT'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Unnamed: 0.3', 'Unnamed: 0.2', 'Unnamed: 0.1', 'Unnamed: 0',\n",
       "       'NCT_NUMBER', 'STUDY_TITLE', 'STUDY_URL', 'STUDY_STATUS', 'CONDITIONS',\n",
       "       'START_DATE', 'COMPLETION_DATE', 'AGE', 'ELIGIBILITY_CRITERIA',\n",
       "       'PRIMARY_OUTCOMES', 'SECONDARY_OUTCOMES', 'INTERVENTIONS',\n",
       "       'POINT_OF_CONTACT', 'LOCATIONS'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_1.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>NCT_NUMBER</th>\n",
       "      <th>STUDY_TITLE</th>\n",
       "      <th>STUDY_URL</th>\n",
       "      <th>STUDY_STATUS</th>\n",
       "      <th>CONDITIONS</th>\n",
       "      <th>LOCATIONS</th>\n",
       "      <th>START_DATE</th>\n",
       "      <th>COMPLETION_DATE</th>\n",
       "      <th>AGE</th>\n",
       "      <th>ELIGIBILITY_CRITERIA</th>\n",
       "      <th>PRIMARY_OUTCOMES</th>\n",
       "      <th>SECONDARY_OUTCOMES</th>\n",
       "      <th>INTERVENTIONS</th>\n",
       "      <th>POINT_OF_CONTACT</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>NCT05664971</td>\n",
       "      <td>JS004 Combined With Toripalimab and With Stand...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05664971</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Advanced Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'Shanghai Chest Hospita...</td>\n",
       "      <td>February 9, 2023</td>\n",
       "      <td>November 17, 2024</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligible participants include males or females...</td>\n",
       "      <td>The primary outcomes include the incidence of ...</td>\n",
       "      <td>Secondary outcomes encompass the duration of r...</td>\n",
       "      <td>The study involves multiple cohorts receiving ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT05902520</td>\n",
       "      <td>Adoptive Cell Therapy Using Cancer Specific CD...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05902520</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>HNSCC, Melanoma, Gynecologic Cancer, Colorecta...</td>\n",
       "      <td>[{'Location Facility': 'Providence Portland Me...</td>\n",
       "      <td>June 19, 2023</td>\n",
       "      <td>May 19, 2026</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes adults over 18 with histo...</td>\n",
       "      <td>The primary outcome is to assess the safety of...</td>\n",
       "      <td>Secondary outcomes include evaluating the effi...</td>\n",
       "      <td>The study involves two experimental arms. Both...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT03917043</td>\n",
       "      <td>APG-2449 in Patients With Advanced Solid Tumors</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03917043</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Advanced Solid Cancer, Non Small Cell Lung Can...</td>\n",
       "      <td>[{'Location Facility': 'Beijing Cancer Hospita...</td>\n",
       "      <td>May 27, 2019</td>\n",
       "      <td>February 2025</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with advanced tu...</td>\n",
       "      <td>The primary outcomes are to determine the maxi...</td>\n",
       "      <td>Secondary outcomes include measuring the maxim...</td>\n",
       "      <td>The intervention involves administering APG-24...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT06249854</td>\n",
       "      <td>Efficacy and Safety of Combination Therapy Wit...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06249854</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Non-small Cell Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'Korea University Ansan...</td>\n",
       "      <td>February 8, 2024</td>\n",
       "      <td>December 31, 2025</td>\n",
       "      <td>19 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes adults aged 19 or older w...</td>\n",
       "      <td>The primary outcome measure is Progression-Fre...</td>\n",
       "      <td>Secondary outcomes include Disease Control Rat...</td>\n",
       "      <td>The study involves two groups: one receiving P...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>7</td>\n",
       "      <td>NCT05777603</td>\n",
       "      <td>Study of Aerosolized Antibiotics and Pembroliz...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05777603</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Advanced Non Small Cell Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'National Institutes of...</td>\n",
       "      <td>February 18, 2024</td>\n",
       "      <td>June 1, 2025</td>\n",
       "      <td>18 Years|120 Years|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes adults (&gt;=18 years) with ...</td>\n",
       "      <td>The primary outcome is to evaluate the safety ...</td>\n",
       "      <td>Secondary outcomes include determining the rec...</td>\n",
       "      <td>The intervention consists of an experimental a...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3809</th>\n",
       "      <td>3809</td>\n",
       "      <td>NCT06091943</td>\n",
       "      <td>Study to Evaluate the Bioavailability of Tisle...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06091943</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Non-small Cell Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'Peking Union Medical C...</td>\n",
       "      <td>November 16, 2023</td>\n",
       "      <td>March 31, 2026</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals able to conse...</td>\n",
       "      <td>Primary outcomes include pharmacokinetic measu...</td>\n",
       "      <td>Secondary outcomes focus on additional pharmac...</td>\n",
       "      <td>The study involves two experimental arms. Part...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3811</th>\n",
       "      <td>3811</td>\n",
       "      <td>NCT04892472</td>\n",
       "      <td>EF-36/Keynote B36: A Pilot, Randomized, Open-l...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04892472</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Non-small Cell Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'Central Alabama Resear...</td>\n",
       "      <td>July 12, 2021</td>\n",
       "      <td>December 2026</td>\n",
       "      <td>22 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals with a confir...</td>\n",
       "      <td>The primary outcome measure is Progression Fre...</td>\n",
       "      <td>Secondary outcomes include Overall Survival (O...</td>\n",
       "      <td>The study involves two experimental arms. Arm ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3812</th>\n",
       "      <td>3812</td>\n",
       "      <td>NCT05236608</td>\n",
       "      <td>A Study to Evaluate the Combination of Nivolum...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05236608</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Metastatic Non Small Cell Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'National Cancer Centre...</td>\n",
       "      <td>November 12, 2021</td>\n",
       "      <td>May 2024</td>\n",
       "      <td>21 Years|99 Years|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with confirmed s...</td>\n",
       "      <td>The study aims to assess the safety profile an...</td>\n",
       "      <td>Secondary outcomes include measuring progressi...</td>\n",
       "      <td>Participants will receive nivolumab and ADG106...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3819</th>\n",
       "      <td>3819</td>\n",
       "      <td>NCT06028152</td>\n",
       "      <td>Using an End-of-life Conversation Game to Enga...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06028152</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer, Lung Cancer, Genito Urinary Cancer</td>\n",
       "      <td>[{'Location Facility': 'Penn State Cancer Inst...</td>\n",
       "      <td>October 31, 2023</td>\n",
       "      <td>November 2024</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility for cancer patients includes being...</td>\n",
       "      <td>The primary outcome is to assess the experienc...</td>\n",
       "      <td>Secondary outcomes include measuring readiness...</td>\n",
       "      <td>Participants in the experimental arm, labeled ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3826</th>\n",
       "      <td>3826</td>\n",
       "      <td>NCT02955290</td>\n",
       "      <td>CIMAvax Vaccine, Nivolumab, and Pembrolizumab ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT02955290</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Advanced Head and Neck Squamous Cell Carcinoma...</td>\n",
       "      <td>[{'Location Facility': 'Indiana University Mel...</td>\n",
       "      <td>December 22, 2016</td>\n",
       "      <td>December 9, 2027</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes ECOG performance status &lt;...</td>\n",
       "      <td>Primary outcomes focus on assessing dose limit...</td>\n",
       "      <td>Secondary outcomes include the incidence of ad...</td>\n",
       "      <td>Interventions involve CIMAvax and nivolumab or...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>632 rows × 15 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0   NCT_NUMBER  \\\n",
       "0              0  NCT05664971   \n",
       "1              1  NCT05902520   \n",
       "2              2  NCT03917043   \n",
       "4              4  NCT06249854   \n",
       "7              7  NCT05777603   \n",
       "...          ...          ...   \n",
       "3809        3809  NCT06091943   \n",
       "3811        3811  NCT04892472   \n",
       "3812        3812  NCT05236608   \n",
       "3819        3819  NCT06028152   \n",
       "3826        3826  NCT02955290   \n",
       "\n",
       "                                            STUDY_TITLE  \\\n",
       "0     JS004 Combined With Toripalimab and With Stand...   \n",
       "1     Adoptive Cell Therapy Using Cancer Specific CD...   \n",
       "2       APG-2449 in Patients With Advanced Solid Tumors   \n",
       "4     Efficacy and Safety of Combination Therapy Wit...   \n",
       "7     Study of Aerosolized Antibiotics and Pembroliz...   \n",
       "...                                                 ...   \n",
       "3809  Study to Evaluate the Bioavailability of Tisle...   \n",
       "3811  EF-36/Keynote B36: A Pilot, Randomized, Open-l...   \n",
       "3812  A Study to Evaluate the Combination of Nivolum...   \n",
       "3819  Using an End-of-life Conversation Game to Enga...   \n",
       "3826  CIMAvax Vaccine, Nivolumab, and Pembrolizumab ...   \n",
       "\n",
       "                                             STUDY_URL STUDY_STATUS  \\\n",
       "0     https://www.clinicaltrials.gov/study/NCT05664971   Recruiting   \n",
       "1     https://www.clinicaltrials.gov/study/NCT05902520   Recruiting   \n",
       "2     https://www.clinicaltrials.gov/study/NCT03917043   Recruiting   \n",
       "4     https://www.clinicaltrials.gov/study/NCT06249854   Recruiting   \n",
       "7     https://www.clinicaltrials.gov/study/NCT05777603   Recruiting   \n",
       "...                                                ...          ...   \n",
       "3809  https://www.clinicaltrials.gov/study/NCT06091943   Recruiting   \n",
       "3811  https://www.clinicaltrials.gov/study/NCT04892472   Recruiting   \n",
       "3812  https://www.clinicaltrials.gov/study/NCT05236608   Recruiting   \n",
       "3819  https://www.clinicaltrials.gov/study/NCT06028152   Recruiting   \n",
       "3826  https://www.clinicaltrials.gov/study/NCT02955290   Recruiting   \n",
       "\n",
       "                                             CONDITIONS  \\\n",
       "0                                  Advanced Lung Cancer   \n",
       "1     HNSCC, Melanoma, Gynecologic Cancer, Colorecta...   \n",
       "2     Advanced Solid Cancer, Non Small Cell Lung Can...   \n",
       "4                            Non-small Cell Lung Cancer   \n",
       "7                   Advanced Non Small Cell Lung Cancer   \n",
       "...                                                 ...   \n",
       "3809                         Non-small Cell Lung Cancer   \n",
       "3811                         Non-small Cell Lung Cancer   \n",
       "3812              Metastatic Non Small Cell Lung Cancer   \n",
       "3819  Breast Cancer, Lung Cancer, Genito Urinary Cancer   \n",
       "3826  Advanced Head and Neck Squamous Cell Carcinoma...   \n",
       "\n",
       "                                              LOCATIONS         START_DATE  \\\n",
       "0     [{'Location Facility': 'Shanghai Chest Hospita...   February 9, 2023   \n",
       "1     [{'Location Facility': 'Providence Portland Me...      June 19, 2023   \n",
       "2     [{'Location Facility': 'Beijing Cancer Hospita...       May 27, 2019   \n",
       "4     [{'Location Facility': 'Korea University Ansan...   February 8, 2024   \n",
       "7     [{'Location Facility': 'National Institutes of...  February 18, 2024   \n",
       "...                                                 ...                ...   \n",
       "3809  [{'Location Facility': 'Peking Union Medical C...  November 16, 2023   \n",
       "3811  [{'Location Facility': 'Central Alabama Resear...      July 12, 2021   \n",
       "3812  [{'Location Facility': 'National Cancer Centre...  November 12, 2021   \n",
       "3819  [{'Location Facility': 'Penn State Cancer Inst...   October 31, 2023   \n",
       "3826  [{'Location Facility': 'Indiana University Mel...  December 22, 2016   \n",
       "\n",
       "        COMPLETION_DATE                                   AGE  \\\n",
       "0     November 17, 2024           18 Years||Adult|Older Adult   \n",
       "1          May 19, 2026           18 Years||Adult|Older Adult   \n",
       "2         February 2025           18 Years||Adult|Older Adult   \n",
       "4     December 31, 2025           19 Years||Adult|Older Adult   \n",
       "7          June 1, 2025  18 Years|120 Years|Adult|Older Adult   \n",
       "...                 ...                                   ...   \n",
       "3809     March 31, 2026           18 Years||Adult|Older Adult   \n",
       "3811      December 2026           22 Years||Adult|Older Adult   \n",
       "3812           May 2024   21 Years|99 Years|Adult|Older Adult   \n",
       "3819      November 2024           18 Years||Adult|Older Adult   \n",
       "3826   December 9, 2027           18 Years||Adult|Older Adult   \n",
       "\n",
       "                                   ELIGIBILITY_CRITERIA  \\\n",
       "0     Eligible participants include males or females...   \n",
       "1     Eligibility includes adults over 18 with histo...   \n",
       "2     Eligibility includes patients with advanced tu...   \n",
       "4     Eligibility includes adults aged 19 or older w...   \n",
       "7     Eligibility includes adults (>=18 years) with ...   \n",
       "...                                                 ...   \n",
       "3809  Eligibility includes individuals able to conse...   \n",
       "3811  Eligibility includes individuals with a confir...   \n",
       "3812  Eligibility includes patients with confirmed s...   \n",
       "3819  Eligibility for cancer patients includes being...   \n",
       "3826  Eligibility includes ECOG performance status <...   \n",
       "\n",
       "                                       PRIMARY_OUTCOMES  \\\n",
       "0     The primary outcomes include the incidence of ...   \n",
       "1     The primary outcome is to assess the safety of...   \n",
       "2     The primary outcomes are to determine the maxi...   \n",
       "4     The primary outcome measure is Progression-Fre...   \n",
       "7     The primary outcome is to evaluate the safety ...   \n",
       "...                                                 ...   \n",
       "3809  Primary outcomes include pharmacokinetic measu...   \n",
       "3811  The primary outcome measure is Progression Fre...   \n",
       "3812  The study aims to assess the safety profile an...   \n",
       "3819  The primary outcome is to assess the experienc...   \n",
       "3826  Primary outcomes focus on assessing dose limit...   \n",
       "\n",
       "                                     SECONDARY_OUTCOMES  \\\n",
       "0     Secondary outcomes encompass the duration of r...   \n",
       "1     Secondary outcomes include evaluating the effi...   \n",
       "2     Secondary outcomes include measuring the maxim...   \n",
       "4     Secondary outcomes include Disease Control Rat...   \n",
       "7     Secondary outcomes include determining the rec...   \n",
       "...                                                 ...   \n",
       "3809  Secondary outcomes focus on additional pharmac...   \n",
       "3811  Secondary outcomes include Overall Survival (O...   \n",
       "3812  Secondary outcomes include measuring progressi...   \n",
       "3819  Secondary outcomes include measuring readiness...   \n",
       "3826  Secondary outcomes include the incidence of ad...   \n",
       "\n",
       "                                          INTERVENTIONS  \\\n",
       "0     The study involves multiple cohorts receiving ...   \n",
       "1     The study involves two experimental arms. Both...   \n",
       "2     The intervention involves administering APG-24...   \n",
       "4     The study involves two groups: one receiving P...   \n",
       "7     The intervention consists of an experimental a...   \n",
       "...                                                 ...   \n",
       "3809  The study involves two experimental arms. Part...   \n",
       "3811  The study involves two experimental arms. Arm ...   \n",
       "3812  Participants will receive nivolumab and ADG106...   \n",
       "3819  Participants in the experimental arm, labeled ...   \n",
       "3826  Interventions involve CIMAvax and nivolumab or...   \n",
       "\n",
       "                                       POINT_OF_CONTACT  \n",
       "0     {'Name': None, 'Organization': None, 'Email': ...  \n",
       "1     {'Name': None, 'Organization': None, 'Email': ...  \n",
       "2     {'Name': None, 'Organization': None, 'Email': ...  \n",
       "4     {'Name': None, 'Organization': None, 'Email': ...  \n",
       "7     {'Name': None, 'Organization': None, 'Email': ...  \n",
       "...                                                 ...  \n",
       "3809  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "3811  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "3812  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "3819  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "3826  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "\n",
       "[632 rows x 15 columns]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lung_cancer_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "output = {\"stage\" : \"stage\",\n",
    "          \"age\" : \"age\",\n",
    "          \"gender\" : \"gender\" }"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "system_prompt = \"\"\"You are helpful assistant to give stage of cancer ,age and gender from given senetence and give output in json format as {output} \"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "ELIGIBILITY_CRITERIA = df[\"ELIGIBILITY_CRITERIA\"][2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Eligibility includes patients with advanced tumors such as non-small cell lung cancer with ALK/ROS1 gene fusion, malignant pleural mesothelioma, esophageal cancer, and ovarian cancer. Specific cohorts for expansion stage include patients with non-small cell lung cancer who have progressed on or are intolerant to second-generation ALK TKI therapy or any ROS1 TKI therapy, and those with ALK/ROS1 fusion gene positive non-small cell lung cancer without prior TKI treatment. Requirements include ECOG Performance Status ≤ 1, life expectancy ≥ 3 months, at least 1 measurable lesion per RECIST 1.1, adequate organ function, controlled brain metastases, and negative pregnancy test for women of childbearing age. Exclusions include concurrent anti-cancer therapy, recent TKI therapy, unresolved toxicities, swallowing difficulties, significant cardiovascular disease, recent surgery, active infections, known allergies to study drug, pregnant or breastfeeding women, and use of certain CYP inhibitors or substrates.'"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"ELIGIBILITY_CRITERIA\"][2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "response = openai.chat.completions.create(\n",
    "            model='gpt-4-0125-preview', \n",
    "            temperature=0,\n",
    "            messages=[\n",
    "                {\"role\":\"system\", \"content\":system_prompt},\n",
    "                {\"role\":\"user\", \"content\":f\"\"\" Extract the stage of cancer, age and gender from given input {ELIGIBILITY_CRITERIA} and give output in {output} format, stricrtly specify gender as male or female \"\"\"},\n",
    "            ],\n",
    "            max_tokens = 1024,\n",
    "            response_format={ \"type\": \"json_object\" }\n",
    "            \n",
    "        )\n",
    "      "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'{\"stage\": \"advanced\", \"age\": \"not specified\", \"gender\": \"not specified\"}'"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response.choices[0].message.content"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['18 Years||Adult|Older Adult', '19 Years||Adult|Older Adult',\n",
       "       '18 Years|75 Years|Adult|Older Adult',\n",
       "       '18 Years|120 Years|Adult|Older Adult',\n",
       "       '18 Years|80 Years|Adult|Older Adult',\n",
       "       '21 Years||Adult|Older Adult',\n",
       "       '45 Years|65 Years|Adult|Older Adult', '65 Years||Older Adult',\n",
       "       '18 Years|99 Years|Adult|Older Adult',\n",
       "       '20 Years|75 Years|Adult|Older Adult', '||Child|Adult|Older Adult',\n",
       "       '18 Years|90 Years|Adult|Older Adult',\n",
       "       '18 Years|70 Years|Adult|Older Adult', '25 Years|60 Years|Adult',\n",
       "       '1 Month||Child|Adult|Older Adult', '40 Years|60 Years|Adult',\n",
       "       '18 Years|39 Years|Adult', '45 Years|49 Years|Adult',\n",
       "       '19 Years|85 Years|Adult|Older Adult',\n",
       "       '18 Years|65 Years|Adult|Older Adult',\n",
       "       '18 Years|100 Years|Adult|Older Adult',\n",
       "       '12 Years||Child|Adult|Older Adult', '50 Years||Adult|Older Adult',\n",
       "       '18 Years|66 Years|Adult|Older Adult',\n",
       "       '19 Years|70 Years|Adult|Older Adult',\n",
       "       '18 Years|69 Years|Adult|Older Adult', '18 Years|60 Years|Adult',\n",
       "       '18 Years|95 Years|Adult|Older Adult',\n",
       "       '18 Years|85 Years|Adult|Older Adult',\n",
       "       '20 Years||Adult|Older Adult',\n",
       "       '3 Years|85 Years|Child|Adult|Older Adult',\n",
       "       '1 Year|25 Years|Child|Adult',\n",
       "       '21 Years|99 Years|Adult|Older Adult', '30 Years|49 Years|Adult',\n",
       "       '40 Years||Adult|Older Adult', '30 Years||Adult|Older Adult',\n",
       "       '19 Years|90 Years|Adult|Older Adult', '18 Years|45 Years|Adult',\n",
       "       '36 Years|60 Years|Adult', '45 Years||Adult|Older Adult',\n",
       "       '18 Years|72 Years|Adult|Older Adult', '20 Years|45 Years|Adult',\n",
       "       '18 Years|74 Years|Adult|Older Adult',\n",
       "       '18 Years|67 Years|Adult|Older Adult',\n",
       "       '60 Years||Adult|Older Adult',\n",
       "       '25 Years|85 Years|Adult|Older Adult',\n",
       "       '45 Years|80 Years|Adult|Older Adult',\n",
       "       '18 Years|130 Years|Adult|Older Adult',\n",
       "       '20 Years|69 Years|Adult|Older Adult',\n",
       "       '3 Years||Child|Adult|Older Adult',\n",
       "       '22 Years|75 Years|Adult|Older Adult',\n",
       "       '50 Years|80 Years|Adult|Older Adult',\n",
       "       '19 Years|110 Years|Adult|Older Adult',\n",
       "       '18 Years|76 Years|Adult|Older Adult',\n",
       "       '45 Years|79 Years|Adult|Older Adult',\n",
       "       '12 Months|30 Years|Child|Adult',\n",
       "       '|80 Years|Child|Adult|Older Adult',\n",
       "       '18 Years|88 Years|Adult|Older Adult',\n",
       "       '25 Years||Adult|Older Adult', '|35 Years|Child|Adult',\n",
       "       '20 Years|70 Years|Adult|Older Adult',\n",
       "       '19 Years|150 Years|Adult|Older Adult',\n",
       "       '25 Years|75 Years|Adult|Older Adult', '21 Years|64 Years|Adult',\n",
       "       '50 Years|74 Years|Adult|Older Adult',\n",
       "       '19 Years|80 Years|Adult|Older Adult', '18 Years|50 Years|Adult',\n",
       "       '25 Years|99 Years|Adult|Older Adult', '20 Years|60 Years|Adult',\n",
       "       '70 Years||Older Adult', '5 Years|17 Years|Child',\n",
       "       '16 Years||Child|Adult|Older Adult',\n",
       "       '14 Years|42 Years|Child|Adult', '15 Years|39 Years|Child|Adult',\n",
       "       '19 Years|100 Years|Adult|Older Adult', '18 Years|44 Years|Adult',\n",
       "       '30 Years|75 Years|Adult|Older Adult',\n",
       "       '50 Years|90 Years|Adult|Older Adult', '18 Years|35 Years|Adult',\n",
       "       '19 Years|99 Years|Adult|Older Adult',\n",
       "       '35 Years|70 Years|Adult|Older Adult', '20 Years|54 Years|Adult',\n",
       "       '40 Years|80 Years|Adult|Older Adult', '45 Years|60 Years|Adult',\n",
       "       '50 Years|69 Years|Adult|Older Adult',\n",
       "       '21 Years|80 Years|Adult|Older Adult',\n",
       "       '20 Years|80 Years|Adult|Older Adult', '18 Years|40 Years|Adult',\n",
       "       '45 Years|74 Years|Adult|Older Adult',\n",
       "       '50 Years|99 Years|Adult|Older Adult',\n",
       "       '50 Years|70 Years|Adult|Older Adult',\n",
       "       '35 Years||Adult|Older Adult', '19 Years|64 Years|Adult',\n",
       "       '16 Years|70 Years|Child|Adult|Older Adult',\n",
       "       '|30 Years|Child|Adult', '45 Years|85 Years|Adult|Older Adult',\n",
       "       '50 Years|100 Years|Adult|Older Adult',\n",
       "       '25 Years|80 Years|Adult|Older Adult', '25 Years|45 Years|Adult',\n",
       "       '15 Years|75 Years|Child|Adult|Older Adult',\n",
       "       '18 Years|55 Years|Adult', '51 Years|74 Years|Adult|Older Adult',\n",
       "       '20 Years|89 Years|Adult|Older Adult',\n",
       "       '22 Years|65 Years|Adult|Older Adult',\n",
       "       '1 Year|19 Years|Child|Adult',\n",
       "       '40 Years|74 Years|Adult|Older Adult',\n",
       "       '18 Years|94 Years|Adult|Older Adult',\n",
       "       '19 Years|69 Years|Adult|Older Adult',\n",
       "       '60 Years|105 Years|Adult|Older Adult',\n",
       "       '50 Years|65 Years|Adult|Older Adult',\n",
       "       '21 Years|75 Years|Adult|Older Adult',\n",
       "       '18 Months||Child|Adult|Older Adult',\n",
       "       '50 Years|67 Years|Adult|Older Adult', '25 Years|49 Years|Adult',\n",
       "       '9 Years|26 Years|Child|Adult',\n",
       "       '20 Years|65 Years|Adult|Older Adult',\n",
       "       '55 Years|75 Years|Adult|Older Adult',\n",
       "       '30 Years|70 Years|Adult|Older Adult',\n",
       "       '40 Years|75 Years|Adult|Older Adult', '35 Years|55 Years|Adult',\n",
       "       '25 Years|50 Years|Adult', '35 Years|65 Years|Adult|Older Adult',\n",
       "       '20 Years|48 Years|Adult', '50 Years|60 Years|Adult',\n",
       "       '22 Years||Adult|Older Adult', '25 Years|55 Years|Adult',\n",
       "       '51 Years||Adult|Older Adult',\n",
       "       '21 Years|70 Years|Adult|Older Adult',\n",
       "       '30 Years|65 Years|Adult|Older Adult',\n",
       "       '23 Years|69 Years|Adult|Older Adult', '|21 Years|Child|Adult',\n",
       "       '21 Years|79 Years|Adult|Older Adult',\n",
       "       '17 Years|70 Years|Child|Adult|Older Adult',\n",
       "       '50 Years|75 Years|Adult|Older Adult',\n",
       "       '40 Years|70 Years|Adult|Older Adult',\n",
       "       '24 Years||Adult|Older Adult',\n",
       "       '40 Years|85 Years|Adult|Older Adult',\n",
       "       '40 Years|69 Years|Adult|Older Adult',\n",
       "       '45 Years|75 Years|Adult|Older Adult',\n",
       "       '19 Years|65 Years|Adult|Older Adult',\n",
       "       '14 Years|100 Years|Child|Adult|Older Adult',\n",
       "       '30 Years|80 Years|Adult|Older Adult', '45 Years|55 Years|Adult',\n",
       "       '10 Years||Child|Adult|Older Adult',\n",
       "       '|85 Years|Child|Adult|Older Adult',\n",
       "       '18 Years|84 Years|Adult|Older Adult',\n",
       "       '13 Years||Child|Adult|Older Adult',\n",
       "       '21 Years|100 Years|Adult|Older Adult', '18 Years|38 Years|Adult',\n",
       "       '|50 Years|Child|Adult', '40 Years|68 Years|Adult|Older Adult',\n",
       "       '2 Years|50 Years|Child|Adult',\n",
       "       '18 Years|89 Years|Adult|Older Adult',\n",
       "       '18 Years|78 Years|Adult|Older Adult',\n",
       "       '55 Years||Adult|Older Adult', '40 Years|50 Years|Adult',\n",
       "       '|60 Years|Child|Adult', '30 Years|79 Years|Adult|Older Adult',\n",
       "       '65 Years|100 Years|Older Adult',\n",
       "       '55 Years|79 Years|Adult|Older Adult',\n",
       "       '18 Years|79 Years|Adult|Older Adult', '20 Years|50 Years|Adult',\n",
       "       '30 Years|39 Years|Adult', '9 Years|45 Years|Child|Adult',\n",
       "       '20 Years|79 Years|Adult|Older Adult',\n",
       "       '35 Years|80 Years|Adult|Older Adult',\n",
       "       '65 Years|111 Years|Older Adult',\n",
       "       '1 Year|75 Years|Child|Adult|Older Adult',\n",
       "       '41 Years||Adult|Older Adult',\n",
       "       '20 Years|85 Years|Adult|Older Adult',\n",
       "       '0 Years||Child|Adult|Older Adult',\n",
       "       '21 Years|65 Years|Adult|Older Adult', '18 Years|49 Years|Adult',\n",
       "       '25 Years|65 Years|Adult|Older Adult', '18 Years|59 Years|Adult',\n",
       "       '40 Years|65 Years|Adult|Older Adult', '39 Years|49 Years|Adult',\n",
       "       '1 Month|99 Years|Child|Adult|Older Adult',\n",
       "       '45 Years|64 Years|Adult', '7 Years||Child|Adult|Older Adult',\n",
       "       '3 Years|30 Years|Child|Adult'], dtype=object)"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"AGE\"].unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "month_df = df[df['AGE'].str.contains('month', case=False)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "79              1 Month||Child|Adult|Older Adult\n",
       "586               12 Months|30 Years|Child|Adult\n",
       "1566          18 Months||Child|Adult|Older Adult\n",
       "2467          18 Months||Child|Adult|Older Adult\n",
       "2507              12 Months|30 Years|Child|Adult\n",
       "3557    1 Month|99 Years|Child|Adult|Older Adult\n",
       "Name: AGE, dtype: object"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "month_df[\"AGE\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_month = month_df.copy()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>NCT_NUMBER</th>\n",
       "      <th>STUDY_TITLE</th>\n",
       "      <th>STUDY_URL</th>\n",
       "      <th>STUDY_STATUS</th>\n",
       "      <th>CONDITIONS</th>\n",
       "      <th>LOCATIONS</th>\n",
       "      <th>START_DATE</th>\n",
       "      <th>COMPLETION_DATE</th>\n",
       "      <th>AGE</th>\n",
       "      <th>ELIGIBILITY_CRITERIA</th>\n",
       "      <th>PRIMARY_OUTCOMES</th>\n",
       "      <th>SECONDARY_OUTCOMES</th>\n",
       "      <th>INTERVENTIONS</th>\n",
       "      <th>POINT_OF_CONTACT</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>79</td>\n",
       "      <td>NCT02595957</td>\n",
       "      <td>Genomic Services Research Program</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT02595957</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Colon Cancer, Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'National Institutes of...</td>\n",
       "      <td>September 16, 2014</td>\n",
       "      <td>December 31, 2028</td>\n",
       "      <td>1 Month||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes English- or Spanish-speak...</td>\n",
       "      <td>The study aims to assess affective responses a...</td>\n",
       "      <td>Not specified.</td>\n",
       "      <td>The study involves two groups: 'Cascade Testin...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>586</th>\n",
       "      <td>586</td>\n",
       "      <td>NCT02574728</td>\n",
       "      <td>Sirolimus in Combination With Metronomic Chemo...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT02574728</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>[{'Location Facility': \"Phoenix Children's Hos...</td>\n",
       "      <td>June 2015</td>\n",
       "      <td>January 2024</td>\n",
       "      <td>12 Months|30 Years|Child|Adult</td>\n",
       "      <td>Eligibility includes participants with relapse...</td>\n",
       "      <td>Primary outcomes focus on the change in radiog...</td>\n",
       "      <td>The secondary outcome is the number of adverse...</td>\n",
       "      <td>Participants will receive oral sirolimus, cele...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1566</th>\n",
       "      <td>1566</td>\n",
       "      <td>NCT04740697</td>\n",
       "      <td>Study to Evaluate the Impact of the Use of Alt...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04740697</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Institut Universitaire...</td>\n",
       "      <td>February 12, 2021</td>\n",
       "      <td>February 2024</td>\n",
       "      <td>18 Months||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals aged ≥ 18 yea...</td>\n",
       "      <td>The primary outcome is the rate of patients wh...</td>\n",
       "      <td>Secondary outcomes include the rate of patient...</td>\n",
       "      <td>Intervention involves patients with localized ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2467</th>\n",
       "      <td>2467</td>\n",
       "      <td>NCT05783908</td>\n",
       "      <td>Impact of Non-magnetic Screen Respiratory Self...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05783908</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Patient With Radiotherapy (Linac MRI), Mobile ...</td>\n",
       "      <td>[{'Location Facility': 'Centre Georges-Françoi...</td>\n",
       "      <td>October 16, 2023</td>\n",
       "      <td>September 27, 2025</td>\n",
       "      <td>18 Months||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals at least 18 y...</td>\n",
       "      <td>The primary outcome is to evaluate the effect ...</td>\n",
       "      <td>Secondary outcomes include measuring patient r...</td>\n",
       "      <td>The study involves two arms: one receiving rad...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2507</th>\n",
       "      <td>2507</td>\n",
       "      <td>NCT05569512</td>\n",
       "      <td>Uproleselan With Pre-Transplant Conditioning i...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05569512</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Acute Myeloid Leukemia, Pediatric Cancer</td>\n",
       "      <td>[{'Location Facility': 'University of Alabama ...</td>\n",
       "      <td>October 6, 2022</td>\n",
       "      <td>December 1, 2028</td>\n",
       "      <td>12 Months|30 Years|Child|Adult</td>\n",
       "      <td>Eligibility includes individuals aged 12 month...</td>\n",
       "      <td>Primary outcomes focus on determining the reco...</td>\n",
       "      <td>Secondary outcomes include uproleselan pharmac...</td>\n",
       "      <td>Participants will receive intravenous (IV) upr...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3557</th>\n",
       "      <td>3557</td>\n",
       "      <td>NCT03896958</td>\n",
       "      <td>The PIONEER Initiative: Precision Insights On ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03896958</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Cancer, All Types, Cancer of Liver, Cancer of ...</td>\n",
       "      <td>[{'Location Facility': 'Specicare', 'Location ...</td>\n",
       "      <td>March 21, 2019</td>\n",
       "      <td>March 12, 2024</td>\n",
       "      <td>1 Month|99 Years|Child|Adult|Older Adult</td>\n",
       "      <td>Inclusion criteria include all patients diagno...</td>\n",
       "      <td>The study focuses on three primary outcomes ov...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>No specific interventions were detailed.</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0   NCT_NUMBER  \\\n",
       "79            79  NCT02595957   \n",
       "586          586  NCT02574728   \n",
       "1566        1566  NCT04740697   \n",
       "2467        2467  NCT05783908   \n",
       "2507        2507  NCT05569512   \n",
       "3557        3557  NCT03896958   \n",
       "\n",
       "                                            STUDY_TITLE  \\\n",
       "79                    Genomic Services Research Program   \n",
       "586   Sirolimus in Combination With Metronomic Chemo...   \n",
       "1566  Study to Evaluate the Impact of the Use of Alt...   \n",
       "2467  Impact of Non-magnetic Screen Respiratory Self...   \n",
       "2507  Uproleselan With Pre-Transplant Conditioning i...   \n",
       "3557  The PIONEER Initiative: Precision Insights On ...   \n",
       "\n",
       "                                             STUDY_URL STUDY_STATUS  \\\n",
       "79    https://www.clinicaltrials.gov/study/NCT02595957   Recruiting   \n",
       "586   https://www.clinicaltrials.gov/study/NCT02574728   Recruiting   \n",
       "1566  https://www.clinicaltrials.gov/study/NCT04740697   Recruiting   \n",
       "2467  https://www.clinicaltrials.gov/study/NCT05783908   Recruiting   \n",
       "2507  https://www.clinicaltrials.gov/study/NCT05569512   Recruiting   \n",
       "3557  https://www.clinicaltrials.gov/study/NCT03896958   Recruiting   \n",
       "\n",
       "                                             CONDITIONS  \\\n",
       "79                          Colon Cancer, Breast Cancer   \n",
       "586                                              Cancer   \n",
       "1566                                      Breast Cancer   \n",
       "2467  Patient With Radiotherapy (Linac MRI), Mobile ...   \n",
       "2507           Acute Myeloid Leukemia, Pediatric Cancer   \n",
       "3557  Cancer, All Types, Cancer of Liver, Cancer of ...   \n",
       "\n",
       "                                              LOCATIONS          START_DATE  \\\n",
       "79    [{'Location Facility': 'National Institutes of...  September 16, 2014   \n",
       "586   [{'Location Facility': \"Phoenix Children's Hos...           June 2015   \n",
       "1566  [{'Location Facility': 'Institut Universitaire...   February 12, 2021   \n",
       "2467  [{'Location Facility': 'Centre Georges-Françoi...    October 16, 2023   \n",
       "2507  [{'Location Facility': 'University of Alabama ...     October 6, 2022   \n",
       "3557  [{'Location Facility': 'Specicare', 'Location ...      March 21, 2019   \n",
       "\n",
       "         COMPLETION_DATE                                       AGE  \\\n",
       "79     December 31, 2028          1 Month||Child|Adult|Older Adult   \n",
       "586         January 2024            12 Months|30 Years|Child|Adult   \n",
       "1566       February 2024        18 Months||Child|Adult|Older Adult   \n",
       "2467  September 27, 2025        18 Months||Child|Adult|Older Adult   \n",
       "2507    December 1, 2028            12 Months|30 Years|Child|Adult   \n",
       "3557      March 12, 2024  1 Month|99 Years|Child|Adult|Older Adult   \n",
       "\n",
       "                                   ELIGIBILITY_CRITERIA  \\\n",
       "79    Eligibility includes English- or Spanish-speak...   \n",
       "586   Eligibility includes participants with relapse...   \n",
       "1566  Eligibility includes individuals aged ≥ 18 yea...   \n",
       "2467  Eligibility includes individuals at least 18 y...   \n",
       "2507  Eligibility includes individuals aged 12 month...   \n",
       "3557  Inclusion criteria include all patients diagno...   \n",
       "\n",
       "                                       PRIMARY_OUTCOMES  \\\n",
       "79    The study aims to assess affective responses a...   \n",
       "586   Primary outcomes focus on the change in radiog...   \n",
       "1566  The primary outcome is the rate of patients wh...   \n",
       "2467  The primary outcome is to evaluate the effect ...   \n",
       "2507  Primary outcomes focus on determining the reco...   \n",
       "3557  The study focuses on three primary outcomes ov...   \n",
       "\n",
       "                                     SECONDARY_OUTCOMES  \\\n",
       "79                                       Not specified.   \n",
       "586   The secondary outcome is the number of adverse...   \n",
       "1566  Secondary outcomes include the rate of patient...   \n",
       "2467  Secondary outcomes include measuring patient r...   \n",
       "2507  Secondary outcomes include uproleselan pharmac...   \n",
       "3557               No secondary outcomes were provided.   \n",
       "\n",
       "                                          INTERVENTIONS  \\\n",
       "79    The study involves two groups: 'Cascade Testin...   \n",
       "586   Participants will receive oral sirolimus, cele...   \n",
       "1566  Intervention involves patients with localized ...   \n",
       "2467  The study involves two arms: one receiving rad...   \n",
       "2507  Participants will receive intravenous (IV) upr...   \n",
       "3557           No specific interventions were detailed.   \n",
       "\n",
       "                                       POINT_OF_CONTACT  \n",
       "79    {'Name': None, 'Organization': None, 'Email': ...  \n",
       "586   {'Name': None, 'Organization': None, 'Email': ...  \n",
       "1566  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "2467  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "2507  {'Name': None, 'Organization': None, 'Email': ...  \n",
       "3557  {'Name': None, 'Organization': None, 'Email': ...  "
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_month"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "\n",
    "# Function to convert age format\n",
    "def convert_age_format(age_info):\n",
    "    # Split the age info by \"|\" and extract numerical values\n",
    "    ages = re.findall(r'\\d+', age_info)\n",
    "    \n",
    "    # Convert the numerical values to integers\n",
    "    ages = [int(age) for age in ages if age]  # Filter out empty strings\n",
    "    \n",
    "    # Check if there are any age values\n",
    "    if ages:\n",
    "        # If there are age values, join them with \"years |\" separator\n",
    "        formatted_ages = \" | \".join(f\"{age} years\" for age in ages)\n",
    "    else:\n",
    "        # If no age values are found, return the original age_info\n",
    "        formatted_ages = age_info\n",
    "    \n",
    "    return formatted_ages"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "\n",
    "# Function to convert age format\n",
    "def convert_age_format_months(age_info):\n",
    "    # Split the age info by \"|\" and extract numerical values\n",
    "    ages = re.findall(r'\\d+', age_info)\n",
    "    \n",
    "    # Convert the numerical values to integers\n",
    "    ages = [int(age) for age in ages if age]  # Filter out empty strings\n",
    "    \n",
    "    # Check if there are any age values\n",
    "    if ages:\n",
    "        # If there are age values, join them with \"years |\" separator\n",
    "        formatted_ages = \" | \".join(f\"{age} months\" for age in ages)\n",
    "    else:\n",
    "        # If no age values are found, return the original age_info\n",
    "        formatted_ages = age_info\n",
    "    \n",
    "    return formatted_ages"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "df[\"formatted_age\"] = month_df[\"AGE\"].apply(convert_age_format_months)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>NCT_NUMBER</th>\n",
       "      <th>STUDY_TITLE</th>\n",
       "      <th>STUDY_URL</th>\n",
       "      <th>STUDY_STATUS</th>\n",
       "      <th>CONDITIONS</th>\n",
       "      <th>LOCATIONS</th>\n",
       "      <th>START_DATE</th>\n",
       "      <th>COMPLETION_DATE</th>\n",
       "      <th>AGE</th>\n",
       "      <th>ELIGIBILITY_CRITERIA</th>\n",
       "      <th>PRIMARY_OUTCOMES</th>\n",
       "      <th>SECONDARY_OUTCOMES</th>\n",
       "      <th>INTERVENTIONS</th>\n",
       "      <th>POINT_OF_CONTACT</th>\n",
       "      <th>formatted_age</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>NCT05664971</td>\n",
       "      <td>JS004 Combined With Toripalimab and With Stand...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05664971</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Advanced Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'Shanghai Chest Hospita...</td>\n",
       "      <td>February 9, 2023</td>\n",
       "      <td>November 17, 2024</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligible participants include males or females...</td>\n",
       "      <td>The primary outcomes include the incidence of ...</td>\n",
       "      <td>Secondary outcomes encompass the duration of r...</td>\n",
       "      <td>The study involves multiple cohorts receiving ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT05902520</td>\n",
       "      <td>Adoptive Cell Therapy Using Cancer Specific CD...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05902520</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>HNSCC, Melanoma, Gynecologic Cancer, Colorecta...</td>\n",
       "      <td>[{'Location Facility': 'Providence Portland Me...</td>\n",
       "      <td>June 19, 2023</td>\n",
       "      <td>May 19, 2026</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes adults over 18 with histo...</td>\n",
       "      <td>The primary outcome is to assess the safety of...</td>\n",
       "      <td>Secondary outcomes include evaluating the effi...</td>\n",
       "      <td>The study involves two experimental arms. Both...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT03917043</td>\n",
       "      <td>APG-2449 in Patients With Advanced Solid Tumors</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03917043</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Advanced Solid Cancer, Non Small Cell Lung Can...</td>\n",
       "      <td>[{'Location Facility': 'Beijing Cancer Hospita...</td>\n",
       "      <td>May 27, 2019</td>\n",
       "      <td>February 2025</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with advanced tu...</td>\n",
       "      <td>The primary outcomes are to determine the maxi...</td>\n",
       "      <td>Secondary outcomes include measuring the maxim...</td>\n",
       "      <td>The intervention involves administering APG-24...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT05674422</td>\n",
       "      <td>GEMCAD-REVEAL STUDY - Circulating Tumor DNA as...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05674422</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Patients With Locally Advanced Rectal Cancer</td>\n",
       "      <td>[{'Location Facility': 'Hospital Germans Trias...</td>\n",
       "      <td>May 26, 2023</td>\n",
       "      <td>July 2026</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligible participants are legally capable indi...</td>\n",
       "      <td>The primary outcome measure is the detection o...</td>\n",
       "      <td>Secondary outcomes include the classification ...</td>\n",
       "      <td>The intervention involves total neoadjuvant th...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT06249854</td>\n",
       "      <td>Efficacy and Safety of Combination Therapy Wit...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06249854</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Non-small Cell Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'Korea University Ansan...</td>\n",
       "      <td>February 8, 2024</td>\n",
       "      <td>December 31, 2025</td>\n",
       "      <td>19 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes adults aged 19 or older w...</td>\n",
       "      <td>The primary outcome measure is Progression-Fre...</td>\n",
       "      <td>Secondary outcomes include Disease Control Rat...</td>\n",
       "      <td>The study involves two groups: one receiving P...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3831</th>\n",
       "      <td>3831</td>\n",
       "      <td>NCT05006131</td>\n",
       "      <td>Pancreatic Cancer Screening for At-risk Indivi...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05006131</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Pancreatic Cancer, Adult</td>\n",
       "      <td>[{'Location Facility': 'Beth Israel Deaconess ...</td>\n",
       "      <td>July 10, 2020</td>\n",
       "      <td>July 10, 2026</td>\n",
       "      <td>18 Years|90 Years|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals indicated for...</td>\n",
       "      <td>The primary outcome is the proportion of scree...</td>\n",
       "      <td>Secondary outcomes include the proportion of s...</td>\n",
       "      <td>The intervention involves screening for pancre...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3832</th>\n",
       "      <td>3832</td>\n",
       "      <td>NCT04679064</td>\n",
       "      <td>Trial on NIraparib-TSR-042 (Dostarlimab) vs Ph...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04679064</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Ovarian Cancer</td>\n",
       "      <td>[{'Location Facility': 'Azienda Ospedaliera Sp...</td>\n",
       "      <td>December 1, 2020</td>\n",
       "      <td>January 1, 2025</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes recurrent ovarian, Fallop...</td>\n",
       "      <td>The primary outcome measure is overall surviva...</td>\n",
       "      <td>Secondary outcomes include progression-free su...</td>\n",
       "      <td>Interventions include a choice of standard che...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3833</th>\n",
       "      <td>3833</td>\n",
       "      <td>NCT04491864</td>\n",
       "      <td>DWIBS-MRI: An Adjunct to the Traditional Diagn...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04491864</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Baylor Scott &amp; White R...</td>\n",
       "      <td>March 11, 2019</td>\n",
       "      <td>March 11, 2024</td>\n",
       "      <td>30 Years||Adult|Older Adult</td>\n",
       "      <td>Eligible participants are genetic females over...</td>\n",
       "      <td>The study aims to assess the accuracy of MRI D...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>The document does not specify interventions, f...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3834</th>\n",
       "      <td>3834</td>\n",
       "      <td>NCT05905939</td>\n",
       "      <td>HER2(Human Epidermal Growth Factor Receptor 2)...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05905939</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Research Site', 'Locat...</td>\n",
       "      <td>May 31, 2023</td>\n",
       "      <td>May 31, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with HER2-positi...</td>\n",
       "      <td>The primary outcomes aim to describe the clini...</td>\n",
       "      <td>Secondary outcomes focus on describing diagnos...</td>\n",
       "      <td>The study does not specify interventions, as i...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3835</th>\n",
       "      <td>3835</td>\n",
       "      <td>NCT03934905</td>\n",
       "      <td>Protective Effects of the Nutritional Suppleme...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03934905</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Anthracycline Related Cardiotoxicity in Breast...</td>\n",
       "      <td>[{'Location Facility': 'Texas Tech University ...</td>\n",
       "      <td>June 1, 2022</td>\n",
       "      <td>June 1, 2026</td>\n",
       "      <td>18 Years|89 Years|Adult|Older Adult</td>\n",
       "      <td>Participants aged 18 to 89, without prior diag...</td>\n",
       "      <td>The primary outcome is the change in cardiac f...</td>\n",
       "      <td>Secondary outcomes include monitoring troponin...</td>\n",
       "      <td>Participants will receive either sulforaphane ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3836 rows × 16 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0   NCT_NUMBER  \\\n",
       "0              0  NCT05664971   \n",
       "1              1  NCT05902520   \n",
       "2              2  NCT03917043   \n",
       "3              3  NCT05674422   \n",
       "4              4  NCT06249854   \n",
       "...          ...          ...   \n",
       "3831        3831  NCT05006131   \n",
       "3832        3832  NCT04679064   \n",
       "3833        3833  NCT04491864   \n",
       "3834        3834  NCT05905939   \n",
       "3835        3835  NCT03934905   \n",
       "\n",
       "                                            STUDY_TITLE  \\\n",
       "0     JS004 Combined With Toripalimab and With Stand...   \n",
       "1     Adoptive Cell Therapy Using Cancer Specific CD...   \n",
       "2       APG-2449 in Patients With Advanced Solid Tumors   \n",
       "3     GEMCAD-REVEAL STUDY - Circulating Tumor DNA as...   \n",
       "4     Efficacy and Safety of Combination Therapy Wit...   \n",
       "...                                                 ...   \n",
       "3831  Pancreatic Cancer Screening for At-risk Indivi...   \n",
       "3832  Trial on NIraparib-TSR-042 (Dostarlimab) vs Ph...   \n",
       "3833  DWIBS-MRI: An Adjunct to the Traditional Diagn...   \n",
       "3834  HER2(Human Epidermal Growth Factor Receptor 2)...   \n",
       "3835  Protective Effects of the Nutritional Suppleme...   \n",
       "\n",
       "                                             STUDY_URL STUDY_STATUS  \\\n",
       "0     https://www.clinicaltrials.gov/study/NCT05664971   Recruiting   \n",
       "1     https://www.clinicaltrials.gov/study/NCT05902520   Recruiting   \n",
       "2     https://www.clinicaltrials.gov/study/NCT03917043   Recruiting   \n",
       "3     https://www.clinicaltrials.gov/study/NCT05674422   Recruiting   \n",
       "4     https://www.clinicaltrials.gov/study/NCT06249854   Recruiting   \n",
       "...                                                ...          ...   \n",
       "3831  https://www.clinicaltrials.gov/study/NCT05006131   Recruiting   \n",
       "3832  https://www.clinicaltrials.gov/study/NCT04679064   Recruiting   \n",
       "3833  https://www.clinicaltrials.gov/study/NCT04491864   Recruiting   \n",
       "3834  https://www.clinicaltrials.gov/study/NCT05905939   Recruiting   \n",
       "3835  https://www.clinicaltrials.gov/study/NCT03934905   Recruiting   \n",
       "\n",
       "                                             CONDITIONS  \\\n",
       "0                                  Advanced Lung Cancer   \n",
       "1     HNSCC, Melanoma, Gynecologic Cancer, Colorecta...   \n",
       "2     Advanced Solid Cancer, Non Small Cell Lung Can...   \n",
       "3          Patients With Locally Advanced Rectal Cancer   \n",
       "4                            Non-small Cell Lung Cancer   \n",
       "...                                                 ...   \n",
       "3831                           Pancreatic Cancer, Adult   \n",
       "3832                                     Ovarian Cancer   \n",
       "3833                                      Breast Cancer   \n",
       "3834                                      Breast Cancer   \n",
       "3835  Anthracycline Related Cardiotoxicity in Breast...   \n",
       "\n",
       "                                              LOCATIONS        START_DATE  \\\n",
       "0     [{'Location Facility': 'Shanghai Chest Hospita...  February 9, 2023   \n",
       "1     [{'Location Facility': 'Providence Portland Me...     June 19, 2023   \n",
       "2     [{'Location Facility': 'Beijing Cancer Hospita...      May 27, 2019   \n",
       "3     [{'Location Facility': 'Hospital Germans Trias...      May 26, 2023   \n",
       "4     [{'Location Facility': 'Korea University Ansan...  February 8, 2024   \n",
       "...                                                 ...               ...   \n",
       "3831  [{'Location Facility': 'Beth Israel Deaconess ...     July 10, 2020   \n",
       "3832  [{'Location Facility': 'Azienda Ospedaliera Sp...  December 1, 2020   \n",
       "3833  [{'Location Facility': 'Baylor Scott & White R...    March 11, 2019   \n",
       "3834  [{'Location Facility': 'Research Site', 'Locat...      May 31, 2023   \n",
       "3835  [{'Location Facility': 'Texas Tech University ...      June 1, 2022   \n",
       "\n",
       "        COMPLETION_DATE                                  AGE  \\\n",
       "0     November 17, 2024          18 Years||Adult|Older Adult   \n",
       "1          May 19, 2026          18 Years||Adult|Older Adult   \n",
       "2         February 2025          18 Years||Adult|Older Adult   \n",
       "3             July 2026          18 Years||Adult|Older Adult   \n",
       "4     December 31, 2025          19 Years||Adult|Older Adult   \n",
       "...                 ...                                  ...   \n",
       "3831      July 10, 2026  18 Years|90 Years|Adult|Older Adult   \n",
       "3832    January 1, 2025          18 Years||Adult|Older Adult   \n",
       "3833     March 11, 2024          30 Years||Adult|Older Adult   \n",
       "3834       May 31, 2024            ||Child|Adult|Older Adult   \n",
       "3835       June 1, 2026  18 Years|89 Years|Adult|Older Adult   \n",
       "\n",
       "                                   ELIGIBILITY_CRITERIA  \\\n",
       "0     Eligible participants include males or females...   \n",
       "1     Eligibility includes adults over 18 with histo...   \n",
       "2     Eligibility includes patients with advanced tu...   \n",
       "3     Eligible participants are legally capable indi...   \n",
       "4     Eligibility includes adults aged 19 or older w...   \n",
       "...                                                 ...   \n",
       "3831  Eligibility includes individuals indicated for...   \n",
       "3832  Eligibility includes recurrent ovarian, Fallop...   \n",
       "3833  Eligible participants are genetic females over...   \n",
       "3834  Eligibility includes patients with HER2-positi...   \n",
       "3835  Participants aged 18 to 89, without prior diag...   \n",
       "\n",
       "                                       PRIMARY_OUTCOMES  \\\n",
       "0     The primary outcomes include the incidence of ...   \n",
       "1     The primary outcome is to assess the safety of...   \n",
       "2     The primary outcomes are to determine the maxi...   \n",
       "3     The primary outcome measure is the detection o...   \n",
       "4     The primary outcome measure is Progression-Fre...   \n",
       "...                                                 ...   \n",
       "3831  The primary outcome is the proportion of scree...   \n",
       "3832  The primary outcome measure is overall surviva...   \n",
       "3833  The study aims to assess the accuracy of MRI D...   \n",
       "3834  The primary outcomes aim to describe the clini...   \n",
       "3835  The primary outcome is the change in cardiac f...   \n",
       "\n",
       "                                     SECONDARY_OUTCOMES  \\\n",
       "0     Secondary outcomes encompass the duration of r...   \n",
       "1     Secondary outcomes include evaluating the effi...   \n",
       "2     Secondary outcomes include measuring the maxim...   \n",
       "3     Secondary outcomes include the classification ...   \n",
       "4     Secondary outcomes include Disease Control Rat...   \n",
       "...                                                 ...   \n",
       "3831  Secondary outcomes include the proportion of s...   \n",
       "3832  Secondary outcomes include progression-free su...   \n",
       "3833               No secondary outcomes were provided.   \n",
       "3834  Secondary outcomes focus on describing diagnos...   \n",
       "3835  Secondary outcomes include monitoring troponin...   \n",
       "\n",
       "                                          INTERVENTIONS  \\\n",
       "0     The study involves multiple cohorts receiving ...   \n",
       "1     The study involves two experimental arms. Both...   \n",
       "2     The intervention involves administering APG-24...   \n",
       "3     The intervention involves total neoadjuvant th...   \n",
       "4     The study involves two groups: one receiving P...   \n",
       "...                                                 ...   \n",
       "3831  The intervention involves screening for pancre...   \n",
       "3832  Interventions include a choice of standard che...   \n",
       "3833  The document does not specify interventions, f...   \n",
       "3834  The study does not specify interventions, as i...   \n",
       "3835  Participants will receive either sulforaphane ...   \n",
       "\n",
       "                                       POINT_OF_CONTACT formatted_age  \n",
       "0     {'Name': None, 'Organization': None, 'Email': ...           NaN  \n",
       "1     {'Name': None, 'Organization': None, 'Email': ...           NaN  \n",
       "2     {'Name': None, 'Organization': None, 'Email': ...           NaN  \n",
       "3     {'Name': None, 'Organization': None, 'Email': ...           NaN  \n",
       "4     {'Name': None, 'Organization': None, 'Email': ...           NaN  \n",
       "...                                                 ...           ...  \n",
       "3831  {'Name': None, 'Organization': None, 'Email': ...           NaN  \n",
       "3832  {'Name': None, 'Organization': None, 'Email': ...           NaN  \n",
       "3833  {'Name': None, 'Organization': None, 'Email': ...           NaN  \n",
       "3834  {'Name': None, 'Organization': None, 'Email': ...           NaN  \n",
       "3835  {'Name': None, 'Organization': None, 'Email': ...           NaN  \n",
       "\n",
       "[3836 rows x 16 columns]"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "df[\"formatted_age\"] = df['AGE'].apply(convert_age_format)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0                        18 years\n",
       "1                        18 years\n",
       "2                        18 years\n",
       "3                        18 years\n",
       "4                        19 years\n",
       "                  ...            \n",
       "3831          18 years | 90 years\n",
       "3832                     18 years\n",
       "3833                     30 years\n",
       "3834    ||Child|Adult|Older Adult\n",
       "3835          18 years | 89 years\n",
       "Name: formatted_age, Length: 3836, dtype: object"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"formatted_age\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0               18 Years||Adult|Older Adult\n",
       "1               18 Years||Adult|Older Adult\n",
       "2               18 Years||Adult|Older Adult\n",
       "3               18 Years||Adult|Older Adult\n",
       "4               19 Years||Adult|Older Adult\n",
       "                       ...                 \n",
       "3831    18 Years|90 Years|Adult|Older Adult\n",
       "3832            18 Years||Adult|Older Adult\n",
       "3833            30 Years||Adult|Older Adult\n",
       "3834              ||Child|Adult|Older Adult\n",
       "3835    18 Years|89 Years|Adult|Older Adult\n",
       "Name: AGE, Length: 3836, dtype: object"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"AGE\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "def has_numerical_age(age_info):\n",
    "    ages = re.findall(r'\\d+', age_info)\n",
    "    return bool(ages) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>NCT_NUMBER</th>\n",
       "      <th>STUDY_TITLE</th>\n",
       "      <th>STUDY_URL</th>\n",
       "      <th>STUDY_STATUS</th>\n",
       "      <th>CONDITIONS</th>\n",
       "      <th>LOCATIONS</th>\n",
       "      <th>START_DATE</th>\n",
       "      <th>COMPLETION_DATE</th>\n",
       "      <th>AGE</th>\n",
       "      <th>ELIGIBILITY_CRITERIA</th>\n",
       "      <th>PRIMARY_OUTCOMES</th>\n",
       "      <th>SECONDARY_OUTCOMES</th>\n",
       "      <th>INTERVENTIONS</th>\n",
       "      <th>POINT_OF_CONTACT</th>\n",
       "      <th>formatted_age</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>35</td>\n",
       "      <td>NCT05364138</td>\n",
       "      <td>Evaluating Scaleup of an Adapted Breast Cancer...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05364138</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer, Benign Breast Disease, Cervix C...</td>\n",
       "      <td>[{'Location Facility': 'Partners in Health (In...</td>\n",
       "      <td>July 31, 2023</td>\n",
       "      <td>March 30, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Inclusion criteria include all individuals eva...</td>\n",
       "      <td>The primary outcome focuses on the number of p...</td>\n",
       "      <td>Secondary outcomes include analyzing the media...</td>\n",
       "      <td>The document does not specify interventions di...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>115</td>\n",
       "      <td>NCT05834686</td>\n",
       "      <td>HER2 Expression of CTC to Predict Response in ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05834686</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'The Fifth Medical Cent...</td>\n",
       "      <td>January 1, 2023</td>\n",
       "      <td>April 2025</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals with patholog...</td>\n",
       "      <td>The primary outcome measure is Progression Fre...</td>\n",
       "      <td>Secondary outcomes include the Objective Respo...</td>\n",
       "      <td>The intervention involves detecting HER2 expre...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>132</th>\n",
       "      <td>132</td>\n",
       "      <td>NCT05770544</td>\n",
       "      <td>DETERMINE Trial Treatment Arm 03: Entrectinib ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05770544</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Solid Tumor, Haematological Malignancy, Malign...</td>\n",
       "      <td>[{'Location Facility': 'Belfast City Hospital'...</td>\n",
       "      <td>June 2024</td>\n",
       "      <td>October 2029</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes adults, teenagers, and ch...</td>\n",
       "      <td>The primary outcomes focus on Objective Respon...</td>\n",
       "      <td>Secondary outcomes include Duration of Respons...</td>\n",
       "      <td>The intervention involves administering entrec...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>227</th>\n",
       "      <td>227</td>\n",
       "      <td>NCT05770102</td>\n",
       "      <td>DETERMINE Trial Treatment Arm 02: Atezolizumab...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05770102</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Malignancy, Malignant Neoplasm, Lymphoprolifer...</td>\n",
       "      <td>[{'Location Facility': 'Belfast City Hospital'...</td>\n",
       "      <td>October 25, 2023</td>\n",
       "      <td>October 2029</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Participants must fulfill eligibility criteria...</td>\n",
       "      <td>The primary outcomes include Objective Respons...</td>\n",
       "      <td>Secondary outcomes encompass Duration of Respo...</td>\n",
       "      <td>The intervention involves administering atezol...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>242</th>\n",
       "      <td>242</td>\n",
       "      <td>NCT05949021</td>\n",
       "      <td>OCTANE: Adjuvant Liposomal Doxorubicin and Car...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05949021</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Triple Negative Breast Cancer (TNBC)</td>\n",
       "      <td>[{'Location Facility': 'RWJBarnabas Health - T...</td>\n",
       "      <td>October 7, 2023</td>\n",
       "      <td>September 30, 2027</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes newly diagnosed early-sta...</td>\n",
       "      <td>The primary outcome is the Disease-Free Surviv...</td>\n",
       "      <td>Secondary outcomes focus on the safety and tox...</td>\n",
       "      <td>The intervention involves a combination of lip...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>296</th>\n",
       "      <td>296</td>\n",
       "      <td>NCT05851677</td>\n",
       "      <td>RC48-ADC in Breast Cancer</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05851677</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Renji Hospital, School...</td>\n",
       "      <td>June 1, 2023</td>\n",
       "      <td>August 2027</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Participants must have histologically confirme...</td>\n",
       "      <td>The primary outcome measure is Progression-Fre...</td>\n",
       "      <td>The secondary outcome focuses on the assessmen...</td>\n",
       "      <td>The intervention involves administering the dr...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>426</th>\n",
       "      <td>426</td>\n",
       "      <td>NCT04660435</td>\n",
       "      <td>To Identify Primary Resistance to CDK4/6 Inhib...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04660435</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Metastatic Breast Cancer, ER Positive Breast C...</td>\n",
       "      <td>[{'Location Facility': 'Hospital Santo Stefano...</td>\n",
       "      <td>September 1, 2020</td>\n",
       "      <td>December 1, 2026</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Women aged 18 or older with ER-positive, HER2-...</td>\n",
       "      <td>The primary outcome measure is progression-fre...</td>\n",
       "      <td>The secondary outcome measure is the clinical ...</td>\n",
       "      <td>The intervention involves a diagnostic test ca...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>436</th>\n",
       "      <td>436</td>\n",
       "      <td>NCT05305092</td>\n",
       "      <td>Assessment of Brain Cognitive Impairment in Br...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05305092</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer, Chemo-brain, Endocrine Therapy</td>\n",
       "      <td>[{'Location Facility': 'Tangdu Hospital', 'Loc...</td>\n",
       "      <td>May 31, 2022</td>\n",
       "      <td>May 30, 2027</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Inclusion criteria include premenopausal women...</td>\n",
       "      <td>The study measures changes in the brain's gray...</td>\n",
       "      <td>Secondary outcomes focus on the change in conc...</td>\n",
       "      <td>Participants undergo PET/MRI scans, complete p...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>546</th>\n",
       "      <td>546</td>\n",
       "      <td>NCT04265937</td>\n",
       "      <td>ScreenIng of Genetic Susceptibility Genes for ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04265937</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer, Genetic Susceptibility</td>\n",
       "      <td>[{'Location Facility': 'Zhen Hu', 'Location Ci...</td>\n",
       "      <td>July 1, 2019</td>\n",
       "      <td>June 30, 2026</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Inclusion criteria include breast cancer patie...</td>\n",
       "      <td>The primary outcome is to measure the frequenc...</td>\n",
       "      <td>Secondary outcomes, measured over 1 year, incl...</td>\n",
       "      <td>The document does not specify interventions, s...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>724</th>\n",
       "      <td>724</td>\n",
       "      <td>NCT03953157</td>\n",
       "      <td>Dietary and Exercise Interventions in Reducing...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03953157</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Anatomic Stage I Breast Cancer AJCC v8, Anatom...</td>\n",
       "      <td>[{'Location Facility': 'UCLA / Jonsson Compreh...</td>\n",
       "      <td>October 7, 2019</td>\n",
       "      <td>June 1, 2025</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes women diagnosed with loca...</td>\n",
       "      <td>Primary outcomes focus on bone mineral density...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>The study involves two experimental arms. Arm ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>868</th>\n",
       "      <td>868</td>\n",
       "      <td>NCT05359120</td>\n",
       "      <td>Pyrotinib Combined With Capecitabine in HER-2 ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05359120</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Henan cancer hospital'...</td>\n",
       "      <td>May 30, 2022</td>\n",
       "      <td>May 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes pathologically diagnosed ...</td>\n",
       "      <td>The primary outcome measure is Time to Failure...</td>\n",
       "      <td>Secondary outcomes include Progression-free su...</td>\n",
       "      <td>Interventions involve patients in three cohort...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1088</th>\n",
       "      <td>1088</td>\n",
       "      <td>NCT05614375</td>\n",
       "      <td>Endoscopic Surgery in the Treatment of Soft Ti...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05614375</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Sarcoma,Soft Tissue, Nasal Cavity Cancer, Para...</td>\n",
       "      <td>[{'Location Facility': 'Yu Hongmeng', 'Locatio...</td>\n",
       "      <td>June 12, 2021</td>\n",
       "      <td>June 12, 2026</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Inclusion criteria include signing the informe...</td>\n",
       "      <td>The primary outcome measure is overall surviva...</td>\n",
       "      <td>Secondary outcomes include local recurrence-fr...</td>\n",
       "      <td>The intervention involves patients with soft t...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1108</th>\n",
       "      <td>1108</td>\n",
       "      <td>NCT00579514</td>\n",
       "      <td>Germline Alterations of Tumor Susceptibility G...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT00579514</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer, Bladder Cancer, Kidney Cancer, ...</td>\n",
       "      <td>[{'Location Facility': 'Memorial Sloan Ketteri...</td>\n",
       "      <td>March 2000</td>\n",
       "      <td>March 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with a histologi...</td>\n",
       "      <td>The primary outcome is to collect anonymized g...</td>\n",
       "      <td>The secondary outcome involves analyzing DNA s...</td>\n",
       "      <td>The intervention involves the PCR/PCR/LDR Stra...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1160</th>\n",
       "      <td>1160</td>\n",
       "      <td>NCT05463796</td>\n",
       "      <td>InAdvance: Surveillance, Prevention, and Inter...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05463796</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Cancer Risk, Cancer Predisposition Syndrome, H...</td>\n",
       "      <td>[{'Location Facility': 'Dana Farber Cancer Ins...</td>\n",
       "      <td>April 25, 2023</td>\n",
       "      <td>March 25, 2032</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Participants include those with hereditary can...</td>\n",
       "      <td>The primary outcome is to identify exposures, ...</td>\n",
       "      <td>No secondary outcomes are provided.</td>\n",
       "      <td>Participants across different risk groups (her...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1173</th>\n",
       "      <td>1173</td>\n",
       "      <td>NCT04367779</td>\n",
       "      <td>Research of Biomarkers of Response to Proton B...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04367779</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Brain Cancer, Meningioma, Sarcoma</td>\n",
       "      <td>[{'Location Facility': 'Centre Léon Bérard', '...</td>\n",
       "      <td>September 24, 2020</td>\n",
       "      <td>June 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes male or female patients o...</td>\n",
       "      <td>The primary outcome is to identify predictive ...</td>\n",
       "      <td>Secondary outcomes include identifying predict...</td>\n",
       "      <td>The study involves pediatric and adult patient...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1199</th>\n",
       "      <td>1199</td>\n",
       "      <td>NCT06223763</td>\n",
       "      <td>SUROVA - Surgery in Ovarian Cancer, Comparing ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06223763</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Epithelial Ovarian Cancer, Fallopian Tube Neop...</td>\n",
       "      <td>[{'Location Facility': 'Clínica Universidad de...</td>\n",
       "      <td>January 1, 2024</td>\n",
       "      <td>June 1, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients over 18 years ol...</td>\n",
       "      <td>The primary outcome measure is the comparison ...</td>\n",
       "      <td>Secondary outcomes include comparing Progressi...</td>\n",
       "      <td>Interventions involve cytoreductive surgery ai...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1204</th>\n",
       "      <td>1204</td>\n",
       "      <td>NCT03050268</td>\n",
       "      <td>Familial Investigations of Childhood Cancer Pr...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03050268</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Acute Leukemia, Adenomatous Polyposis, Adrenoc...</td>\n",
       "      <td>[{'Location Facility': \"St. Jude Children's Re...</td>\n",
       "      <td>April 6, 2017</td>\n",
       "      <td>March 31, 2037</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>This study targets individuals with a history ...</td>\n",
       "      <td>The primary outcome of the study is the identi...</td>\n",
       "      <td>Not specified.</td>\n",
       "      <td>Not specified.</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1270</th>\n",
       "      <td>1270</td>\n",
       "      <td>NCT04428515</td>\n",
       "      <td>Pilot Study to Evaluate Photoacoustic Imaging ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04428515</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Head and Neck Cancer</td>\n",
       "      <td>[{'Location Facility': 'Sunnybrook Health Scie...</td>\n",
       "      <td>April 23, 2019</td>\n",
       "      <td>April 23, 2027</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals with histolog...</td>\n",
       "      <td>The primary outcome focuses on the correlation...</td>\n",
       "      <td>Secondary outcomes aim to correlate changes in...</td>\n",
       "      <td>The intervention involves the use of a Photoac...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1326</th>\n",
       "      <td>1326</td>\n",
       "      <td>NCT00898131</td>\n",
       "      <td>Collecting Tissue Samples for Future Research ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT00898131</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Robert H. Lurie Compre...</td>\n",
       "      <td>August 2001</td>\n",
       "      <td>January 2025</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Participants are eligible if they are undergoi...</td>\n",
       "      <td>The primary outcome is to collect human breast...</td>\n",
       "      <td>Not specified.</td>\n",
       "      <td>Not specified.</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1371</th>\n",
       "      <td>1371</td>\n",
       "      <td>NCT00196833</td>\n",
       "      <td>Breast Cancer in Pregnancy Register Study</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT00196833</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'German Breast Group', ...</td>\n",
       "      <td>April 2003</td>\n",
       "      <td>April 2026</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Women with histologically confirmed breast can...</td>\n",
       "      <td>Not specified.</td>\n",
       "      <td>Not specified.</td>\n",
       "      <td>Not specified.</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1380</th>\n",
       "      <td>1380</td>\n",
       "      <td>NCT04947280</td>\n",
       "      <td>Single Arm Phase II Study of Fractionated Ster...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04947280</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Bone Metastases, Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Fudan University Shang...</td>\n",
       "      <td>January 1, 2021</td>\n",
       "      <td>December 31, 2026</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals with invasive...</td>\n",
       "      <td>The primary outcome measure is the local contr...</td>\n",
       "      <td>Secondary outcomes include evaluating pain con...</td>\n",
       "      <td>The intervention involves participants being p...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1538</th>\n",
       "      <td>1538</td>\n",
       "      <td>NCT05010863</td>\n",
       "      <td>Gastric Cancer Marker Detection and Its Kit De...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05010863</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Gastric Cancer</td>\n",
       "      <td>[{'Location Facility': 'No. 109, Xueyuan West ...</td>\n",
       "      <td>January 1, 2021</td>\n",
       "      <td>December 30, 2030</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients aged ≥18 years w...</td>\n",
       "      <td>The primary outcome is to obtain subject serum...</td>\n",
       "      <td>No secondary outcomes are specified.</td>\n",
       "      <td>The intervention involves blood collection fro...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1692</th>\n",
       "      <td>1692</td>\n",
       "      <td>NCT05913440</td>\n",
       "      <td>HER2-low Unresectable and/or Metastatic Breast...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05913440</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Research Site', 'Locat...</td>\n",
       "      <td>May 30, 2023</td>\n",
       "      <td>May 31, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with confirmed d...</td>\n",
       "      <td>The study aims to assess the overall prevalenc...</td>\n",
       "      <td>Secondary objectives include describing diagno...</td>\n",
       "      <td>The document does not specify interventions, s...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1693</th>\n",
       "      <td>1693</td>\n",
       "      <td>NCT04996615</td>\n",
       "      <td>Artificial Intelligence Analysis for Magnetic ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04996615</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer, Magnetic Resonance Imaging</td>\n",
       "      <td>[{'Location Facility': \"Peking university peop...</td>\n",
       "      <td>September 1, 2021</td>\n",
       "      <td>September 30, 2025</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients undergoing full ...</td>\n",
       "      <td>The primary outcome is to compare the rates of...</td>\n",
       "      <td>Secondary outcomes involve comparing the sensi...</td>\n",
       "      <td>The intervention involves women at high risk o...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1724</th>\n",
       "      <td>1724</td>\n",
       "      <td>NCT04680442</td>\n",
       "      <td>Safety of Continuing HER-2 Directed Therapy in...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04680442</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer, Heart Failure</td>\n",
       "      <td>[{'Location Facility': 'Hospital de Clínicas d...</td>\n",
       "      <td>July 1, 2021</td>\n",
       "      <td>December 1, 2025</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Participants must have Stage I-III HER-2 posit...</td>\n",
       "      <td>The primary outcomes focus on the efficacy and...</td>\n",
       "      <td>The secondary outcome measures the composite o...</td>\n",
       "      <td>The study involves two groups: a control group...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1725</th>\n",
       "      <td>1725</td>\n",
       "      <td>NCT02695121</td>\n",
       "      <td>Cancer in Patients on Dapagliflozin and Other ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT02695121</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer, Bladder Cancer</td>\n",
       "      <td>[{'Location Facility': 'Research Site', 'Locat...</td>\n",
       "      <td>January 1, 2017</td>\n",
       "      <td>December 31, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Inclusion criteria include patients newly pres...</td>\n",
       "      <td>The primary outcomes focus on the incidence of...</td>\n",
       "      <td>The secondary outcome measures the incidence o...</td>\n",
       "      <td>The document does not specify interventions, s...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1731</th>\n",
       "      <td>1731</td>\n",
       "      <td>NCT05428527</td>\n",
       "      <td>Real-world Clinical Benefit Evaluation in Brea...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05428527</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Cancer-related Fatigue</td>\n",
       "      <td>[{'Location Facility': 'E-Da Cancer Hospital',...</td>\n",
       "      <td>September 8, 2021</td>\n",
       "      <td>December 31, 2023</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Inclusion criteria include breast cancer patie...</td>\n",
       "      <td>The primary outcome measure is the improvement...</td>\n",
       "      <td>Secondary outcomes include the level of fatigu...</td>\n",
       "      <td>The intervention involves breast cancer patien...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1751</th>\n",
       "      <td>1751</td>\n",
       "      <td>NCT05374603</td>\n",
       "      <td>Savolitinib Combine With Durvalumab in EGFR Wi...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05374603</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'Research Site', 'Locat...</td>\n",
       "      <td>November 23, 2022</td>\n",
       "      <td>December 31, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients 18 years or olde...</td>\n",
       "      <td>The primary outcome measure is Progression-Fre...</td>\n",
       "      <td>Secondary outcomes include Objective Response ...</td>\n",
       "      <td>The intervention involves a combination of two...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1784</th>\n",
       "      <td>1784</td>\n",
       "      <td>NCT04567420</td>\n",
       "      <td>DNA-Guided Second Line Adjuvant Therapy For Hi...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04567420</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'University of Arizona ...</td>\n",
       "      <td>February 9, 2021</td>\n",
       "      <td>December 15, 2026</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes Stage II or III, HER2 neg...</td>\n",
       "      <td>The primary outcomes focus on two phases: the ...</td>\n",
       "      <td>Secondary outcomes include assessing the feasi...</td>\n",
       "      <td>The study involves two arms: Arm A (experiment...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1793</th>\n",
       "      <td>1793</td>\n",
       "      <td>NCT05665660</td>\n",
       "      <td>Developing and Evaluating Culturally Relevant ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05665660</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Center for Indigenous ...</td>\n",
       "      <td>June 6, 2023</td>\n",
       "      <td>December 2025</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes women referred for screen...</td>\n",
       "      <td>The primary outcome measure is the uptake of m...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>The study involves two experimental arms. The ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1834</th>\n",
       "      <td>1834</td>\n",
       "      <td>NCT05060068</td>\n",
       "      <td>Effect of Intravenous S-ketamine on Opioid Con...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05060068</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer Surgery</td>\n",
       "      <td>[{'Location Facility': 'Second Affiliated Hosp...</td>\n",
       "      <td>October 7, 2021</td>\n",
       "      <td>July 7, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes female patients with an A...</td>\n",
       "      <td>The primary outcome measure is the consumption...</td>\n",
       "      <td>Secondary outcomes include postoperative pain ...</td>\n",
       "      <td>The study involves three arms: a placebo group...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1982</th>\n",
       "      <td>1982</td>\n",
       "      <td>NCT05932121</td>\n",
       "      <td>Cross-sectional Case and Control Study on Qual...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05932121</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Papillary Thyroid Carcinoma, Thyroid Cancer</td>\n",
       "      <td>[{'Location Facility': 'Department of General ...</td>\n",
       "      <td>June 25, 2023</td>\n",
       "      <td>July 31, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Inclusion criteria include PTC patients who un...</td>\n",
       "      <td>The primary outcome focuses on the cosmetic ou...</td>\n",
       "      <td>Secondary outcomes include the evaluation of t...</td>\n",
       "      <td>The study involves two groups of PTC patients ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2033</th>\n",
       "      <td>2033</td>\n",
       "      <td>NCT05179824</td>\n",
       "      <td>Tempus Priority Study: A Pan-tumor Observation...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05179824</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer, Prostate Cancer, Bladder Cancer...</td>\n",
       "      <td>[{'Location Facility': 'Providence Medical Fou...</td>\n",
       "      <td>October 19, 2020</td>\n",
       "      <td>October 19, 2030</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals with solid or...</td>\n",
       "      <td>The primary outcome is to create a robust data...</td>\n",
       "      <td>Secondary outcomes include documenting specifi...</td>\n",
       "      <td>The study involves two groups, both under the ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2081</th>\n",
       "      <td>2081</td>\n",
       "      <td>NCT05769517</td>\n",
       "      <td>PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEA...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05769517</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>BRCA Mutation, Ovarian Cancer, Ultrasound Ther...</td>\n",
       "      <td>[{'Location Facility': 'Fondazione Policlinico...</td>\n",
       "      <td>March 20, 2023</td>\n",
       "      <td>May 2, 2026</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Participants must have available gBRCA1/2 test...</td>\n",
       "      <td>The study aims to enhance and prospectively va...</td>\n",
       "      <td>No secondary outcomes are provided.</td>\n",
       "      <td>The intervention involves conducting a multice...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2108</th>\n",
       "      <td>2108</td>\n",
       "      <td>NCT05228106</td>\n",
       "      <td>68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05228106</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Solid Cancers</td>\n",
       "      <td>[{'Location Facility': 'CHUS', 'Location City'...</td>\n",
       "      <td>January 21, 2022</td>\n",
       "      <td>January 31, 2027</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligible participants include those with a cli...</td>\n",
       "      <td>The primary outcome focuses on the incidence o...</td>\n",
       "      <td>Secondary outcomes aim to generate clinical in...</td>\n",
       "      <td>The intervention involves an intravenous injec...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2137</th>\n",
       "      <td>2137</td>\n",
       "      <td>NCT04068168</td>\n",
       "      <td>Open Label, Multicenter, Real World Practice o...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04068168</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'Research Site', 'Locat...</td>\n",
       "      <td>January 30, 2020</td>\n",
       "      <td>August 31, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Inclusion criteria include patients eligible f...</td>\n",
       "      <td>The primary outcomes focus on assessing the sa...</td>\n",
       "      <td>Secondary outcomes aim to evaluate the efficac...</td>\n",
       "      <td>The document does not provide specific details...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2418</th>\n",
       "      <td>2418</td>\n",
       "      <td>NCT03452774</td>\n",
       "      <td>SYNERGY-AI: Artificial Intelligence Based Prec...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03452774</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Cancer, Metastatic, Cancer, Cancer of Pancreas...</td>\n",
       "      <td>[{'Location Facility': 'Massive Bio, Inc', 'Lo...</td>\n",
       "      <td>January 1, 2018</td>\n",
       "      <td>June 2025</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with solid and h...</td>\n",
       "      <td>The primary outcome measure is the proportion ...</td>\n",
       "      <td>Secondary outcomes include the impact of CTE o...</td>\n",
       "      <td>The intervention involves Clinical Trial Match...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2464</th>\n",
       "      <td>2464</td>\n",
       "      <td>NCT02302742</td>\n",
       "      <td>Triple Negative Breast Cancer and Germline Her...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT02302742</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer, Hereditary Breast and Ovarian C...</td>\n",
       "      <td>[{'Location Facility': 'Hays Medical Center Dr...</td>\n",
       "      <td>March 22, 2011</td>\n",
       "      <td>December 2025</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes Triple Negative Breast Ca...</td>\n",
       "      <td>The primary outcomes include the prevalence of...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>The study does not involve any interventions a...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2537</th>\n",
       "      <td>2537</td>\n",
       "      <td>NCT05601388</td>\n",
       "      <td>Role of IMP3 Expression in Colorectal Carcinom...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05601388</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Colorectal Cancer</td>\n",
       "      <td>[{'Location Facility': 'Faculty of Medicine', ...</td>\n",
       "      <td>October 1, 2022</td>\n",
       "      <td>June 1, 2023</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Inclusion criteria include patients with color...</td>\n",
       "      <td>The primary outcome is to evaluate the immunoh...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>No interventions were specified.</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2545</th>\n",
       "      <td>2545</td>\n",
       "      <td>NCT05564377</td>\n",
       "      <td>Targeted Therapy Directed by Genetic Testing i...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05564377</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Advanced Malignant Solid Neoplasm, Anatomic St...</td>\n",
       "      <td>[{'Location Facility': 'University of Alabama ...</td>\n",
       "      <td>April 7, 2023</td>\n",
       "      <td>July 1, 2030</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with measurable ...</td>\n",
       "      <td>Primary outcomes focus on the accrual, assignm...</td>\n",
       "      <td>Secondary outcomes include the rate of positiv...</td>\n",
       "      <td>Interventions vary across multiple experimenta...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2609</th>\n",
       "      <td>2609</td>\n",
       "      <td>NCT05834699</td>\n",
       "      <td>HER2 Expression of CTC to Predict Response in ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05834699</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'The Fifth Medical Cent...</td>\n",
       "      <td>January 1, 2023</td>\n",
       "      <td>April 2025</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals with patholog...</td>\n",
       "      <td>The primary outcome measure is Progression Fre...</td>\n",
       "      <td>Secondary outcomes include the Objective Respo...</td>\n",
       "      <td>The intervention involves detecting HER2 expre...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2616</th>\n",
       "      <td>2616</td>\n",
       "      <td>NCT05677308</td>\n",
       "      <td>LYNPARZA Breast Cancer in the Adjuvant Setting...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05677308</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Research Site', 'Locat...</td>\n",
       "      <td>March 7, 2023</td>\n",
       "      <td>December 31, 2026</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients initiating treat...</td>\n",
       "      <td>The primary outcome is to measure the incidenc...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>No specific interventions were detailed.</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2618</th>\n",
       "      <td>2618</td>\n",
       "      <td>NCT04050423</td>\n",
       "      <td>Investigation of Ultrasound Imaging and Spectr...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04050423</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Sunnybrook Health Scie...</td>\n",
       "      <td>September 23, 2014</td>\n",
       "      <td>September 2029</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes both women and men with s...</td>\n",
       "      <td>The primary outcome is to select the best quan...</td>\n",
       "      <td>The secondary outcome focuses on correlating t...</td>\n",
       "      <td>The document does not specify interventions, s...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2644</th>\n",
       "      <td>2644</td>\n",
       "      <td>NCT04428528</td>\n",
       "      <td>Photoacoustic Imaging for Characterizing Breas...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04428528</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Sunnybrook Health Scie...</td>\n",
       "      <td>February 13, 2017</td>\n",
       "      <td>February 13, 2029</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes men and women aged 20-80,...</td>\n",
       "      <td>The primary outcome focuses on correlating tre...</td>\n",
       "      <td>The secondary outcome aims to investigate if b...</td>\n",
       "      <td>The study involves two arms using the Photoaco...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2691</th>\n",
       "      <td>2691</td>\n",
       "      <td>NCT02206984</td>\n",
       "      <td>Endocrine Response in Women With Invasive Lobu...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT02206984</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'UAB Comprehensive Canc...</td>\n",
       "      <td>September 30, 2015</td>\n",
       "      <td>March 2023</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes women with histologically...</td>\n",
       "      <td>The primary outcome measure is the change in K...</td>\n",
       "      <td>Secondary outcomes include measuring estrogen ...</td>\n",
       "      <td>The study involves three active comparator arm...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2794</th>\n",
       "      <td>2794</td>\n",
       "      <td>NCT05483712</td>\n",
       "      <td>Brass Mesh Bolus in Rotational Post-Mastectomy...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05483712</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Nova Scotia Health Aut...</td>\n",
       "      <td>January 18, 2023</td>\n",
       "      <td>November 21, 2023</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Women undergoing rotational chest wall radioth...</td>\n",
       "      <td>The primary outcome measure is the skin dose e...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>The intervention involves patients undergoing ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2985</th>\n",
       "      <td>2985</td>\n",
       "      <td>NCT03687151</td>\n",
       "      <td>Population-based Cancer Observatory</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03687151</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>[{'Location Facility': 'Nice University Hospit...</td>\n",
       "      <td>January 1, 2005</td>\n",
       "      <td>December 31, 2050</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Inclusion criteria include all subjects diagno...</td>\n",
       "      <td>The primary outcome is the enumeration of each...</td>\n",
       "      <td>No secondary outcomes are specified.</td>\n",
       "      <td>The study involves an observational interventi...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3242</th>\n",
       "      <td>3242</td>\n",
       "      <td>NCT00437879</td>\n",
       "      <td>Ultrasound Imaging, Spectroscopy and Ultrasoun...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT00437879</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer Invasive</td>\n",
       "      <td>[{'Location Facility': 'Sunnybrook Health Scie...</td>\n",
       "      <td>December 17, 2008</td>\n",
       "      <td>June 2029</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals with histolog...</td>\n",
       "      <td>The primary outcome involves correlating chang...</td>\n",
       "      <td>Secondary outcomes focus on examining changes ...</td>\n",
       "      <td>The document does not specify interventions di...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3250</th>\n",
       "      <td>3250</td>\n",
       "      <td>NCT03578380</td>\n",
       "      <td>Supermicrosurgery for Breast Cancer Survivors ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03578380</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Secondary Lymphedema, Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Sykehuset Telemark', '...</td>\n",
       "      <td>January 26, 2016</td>\n",
       "      <td>December 31, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Participants are eligible if they have unilate...</td>\n",
       "      <td>The primary outcome measure is the volume of t...</td>\n",
       "      <td>The secondary outcome is the health-related qu...</td>\n",
       "      <td>The study involves two arms: the experimental ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3314</th>\n",
       "      <td>3314</td>\n",
       "      <td>NCT05440929</td>\n",
       "      <td>Evaluation of the Acceptability, Appropriatene...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05440929</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Metastatic Breast Cancer, End of Life</td>\n",
       "      <td>[{'Location Facility': 'University of North Ca...</td>\n",
       "      <td>July 15, 2022</td>\n",
       "      <td>July 15, 2025</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Participants must have verbal informed consent...</td>\n",
       "      <td>The primary outcomes focus on identifying key ...</td>\n",
       "      <td>Secondary outcomes aim to identify key barrier...</td>\n",
       "      <td>The intervention involves conducting semi-stru...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3328</th>\n",
       "      <td>3328</td>\n",
       "      <td>NCT03941639</td>\n",
       "      <td>Using Imaging Data and Genomic Data to Predict...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03941639</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'The Chinese University...</td>\n",
       "      <td>September 1, 2019</td>\n",
       "      <td>June 1, 2025</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Individuals are eligible if they have a clinic...</td>\n",
       "      <td>The primary outcome is the area under the rece...</td>\n",
       "      <td>Not specified.</td>\n",
       "      <td>Not specified.</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3370</th>\n",
       "      <td>3370</td>\n",
       "      <td>NCT05770037</td>\n",
       "      <td>DETERMINE Trial Treatment Arm 01: Alectinib in...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05770037</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Solid Tumor, Haematological Malignancy, Malign...</td>\n",
       "      <td>[{'Location Facility': 'Belfast City Hospital'...</td>\n",
       "      <td>December 18, 2023</td>\n",
       "      <td>October 2029</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes adults, teenagers, and ch...</td>\n",
       "      <td>The primary outcomes are Objective Response (O...</td>\n",
       "      <td>Secondary outcomes include Duration of Respons...</td>\n",
       "      <td>The intervention involves administering alecti...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3512</th>\n",
       "      <td>3512</td>\n",
       "      <td>NCT04549571</td>\n",
       "      <td>Improving Patient-Centered Communication in Br...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04549571</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Anatomic Stage 0 Breast Cancer AJCC v8, Anatom...</td>\n",
       "      <td>[{'Location Facility': 'Kaiser Permanente-Vall...</td>\n",
       "      <td>January 15, 2021</td>\n",
       "      <td>January 2027</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes women aged 21-84, newly d...</td>\n",
       "      <td>The primary outcome is patient knowledge about...</td>\n",
       "      <td>Secondary outcomes include patient self-effica...</td>\n",
       "      <td>Interventions involve patients using the iCanD...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3531</th>\n",
       "      <td>3531</td>\n",
       "      <td>NCT03995082</td>\n",
       "      <td>Breast Cancer Patient Engagement With Patient ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03995082</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'University of Colorado...</td>\n",
       "      <td>October 30, 2019</td>\n",
       "      <td>June 2025</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>The study targets adult females (18 years or o...</td>\n",
       "      <td>The primary outcome is patient satisfaction wi...</td>\n",
       "      <td>Secondary outcomes include various BREAST Q Pa...</td>\n",
       "      <td>Participants in the experimental group will re...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3537</th>\n",
       "      <td>3537</td>\n",
       "      <td>NCT05044689</td>\n",
       "      <td>Case Control Study to Identify Modifiable Risk...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05044689</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Colorectal Cancer, Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Obafemi Awolowo Univer...</td>\n",
       "      <td>April 12, 2021</td>\n",
       "      <td>April 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>For the case group, patients must have a histo...</td>\n",
       "      <td>The primary outcomes include the development a...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>The study involves two main interventions acro...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3665</th>\n",
       "      <td>3665</td>\n",
       "      <td>NCT05601440</td>\n",
       "      <td>Liquid-biopsy Informed Platform Trial to Evalu...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05601440</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'BCCA - Cancer Centre f...</td>\n",
       "      <td>June 13, 2023</td>\n",
       "      <td>June 2028</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes adults (≥18 years) with h...</td>\n",
       "      <td>The primary outcomes focus on evaluating the i...</td>\n",
       "      <td>Secondary outcomes include assessing the numbe...</td>\n",
       "      <td>The study involves three experimental arms: Su...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3822</th>\n",
       "      <td>3822</td>\n",
       "      <td>NCT05631873</td>\n",
       "      <td>Colonoscopy Screening: Setting Epic Follow-up ...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05631873</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Concordance Between Colonoscopy Follow up Inte...</td>\n",
       "      <td>[{'Location Facility': 'Massachusetts General ...</td>\n",
       "      <td>November 18, 2022</td>\n",
       "      <td>June 30, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Inclusion criteria focus on GI specialists at ...</td>\n",
       "      <td>The primary outcomes involve implementing a ne...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>The intervention consists of a research assist...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3834</th>\n",
       "      <td>3834</td>\n",
       "      <td>NCT05905939</td>\n",
       "      <td>HER2(Human Epidermal Growth Factor Receptor 2)...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05905939</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Research Site', 'Locat...</td>\n",
       "      <td>May 31, 2023</td>\n",
       "      <td>May 31, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with HER2-positi...</td>\n",
       "      <td>The primary outcomes aim to describe the clini...</td>\n",
       "      <td>Secondary outcomes focus on describing diagnos...</td>\n",
       "      <td>The study does not specify interventions, as i...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0   NCT_NUMBER  \\\n",
       "35            35  NCT05364138   \n",
       "115          115  NCT05834686   \n",
       "132          132  NCT05770544   \n",
       "227          227  NCT05770102   \n",
       "242          242  NCT05949021   \n",
       "296          296  NCT05851677   \n",
       "426          426  NCT04660435   \n",
       "436          436  NCT05305092   \n",
       "546          546  NCT04265937   \n",
       "724          724  NCT03953157   \n",
       "868          868  NCT05359120   \n",
       "1088        1088  NCT05614375   \n",
       "1108        1108  NCT00579514   \n",
       "1160        1160  NCT05463796   \n",
       "1173        1173  NCT04367779   \n",
       "1199        1199  NCT06223763   \n",
       "1204        1204  NCT03050268   \n",
       "1270        1270  NCT04428515   \n",
       "1326        1326  NCT00898131   \n",
       "1371        1371  NCT00196833   \n",
       "1380        1380  NCT04947280   \n",
       "1538        1538  NCT05010863   \n",
       "1692        1692  NCT05913440   \n",
       "1693        1693  NCT04996615   \n",
       "1724        1724  NCT04680442   \n",
       "1725        1725  NCT02695121   \n",
       "1731        1731  NCT05428527   \n",
       "1751        1751  NCT05374603   \n",
       "1784        1784  NCT04567420   \n",
       "1793        1793  NCT05665660   \n",
       "1834        1834  NCT05060068   \n",
       "1982        1982  NCT05932121   \n",
       "2033        2033  NCT05179824   \n",
       "2081        2081  NCT05769517   \n",
       "2108        2108  NCT05228106   \n",
       "2137        2137  NCT04068168   \n",
       "2418        2418  NCT03452774   \n",
       "2464        2464  NCT02302742   \n",
       "2537        2537  NCT05601388   \n",
       "2545        2545  NCT05564377   \n",
       "2609        2609  NCT05834699   \n",
       "2616        2616  NCT05677308   \n",
       "2618        2618  NCT04050423   \n",
       "2644        2644  NCT04428528   \n",
       "2691        2691  NCT02206984   \n",
       "2794        2794  NCT05483712   \n",
       "2985        2985  NCT03687151   \n",
       "3242        3242  NCT00437879   \n",
       "3250        3250  NCT03578380   \n",
       "3314        3314  NCT05440929   \n",
       "3328        3328  NCT03941639   \n",
       "3370        3370  NCT05770037   \n",
       "3512        3512  NCT04549571   \n",
       "3531        3531  NCT03995082   \n",
       "3537        3537  NCT05044689   \n",
       "3665        3665  NCT05601440   \n",
       "3822        3822  NCT05631873   \n",
       "3834        3834  NCT05905939   \n",
       "\n",
       "                                            STUDY_TITLE  \\\n",
       "35    Evaluating Scaleup of an Adapted Breast Cancer...   \n",
       "115   HER2 Expression of CTC to Predict Response in ...   \n",
       "132   DETERMINE Trial Treatment Arm 03: Entrectinib ...   \n",
       "227   DETERMINE Trial Treatment Arm 02: Atezolizumab...   \n",
       "242   OCTANE: Adjuvant Liposomal Doxorubicin and Car...   \n",
       "296                           RC48-ADC in Breast Cancer   \n",
       "426   To Identify Primary Resistance to CDK4/6 Inhib...   \n",
       "436   Assessment of Brain Cognitive Impairment in Br...   \n",
       "546   ScreenIng of Genetic Susceptibility Genes for ...   \n",
       "724   Dietary and Exercise Interventions in Reducing...   \n",
       "868   Pyrotinib Combined With Capecitabine in HER-2 ...   \n",
       "1088  Endoscopic Surgery in the Treatment of Soft Ti...   \n",
       "1108  Germline Alterations of Tumor Susceptibility G...   \n",
       "1160  InAdvance: Surveillance, Prevention, and Inter...   \n",
       "1173  Research of Biomarkers of Response to Proton B...   \n",
       "1199  SUROVA - Surgery in Ovarian Cancer, Comparing ...   \n",
       "1204  Familial Investigations of Childhood Cancer Pr...   \n",
       "1270  Pilot Study to Evaluate Photoacoustic Imaging ...   \n",
       "1326  Collecting Tissue Samples for Future Research ...   \n",
       "1371          Breast Cancer in Pregnancy Register Study   \n",
       "1380  Single Arm Phase II Study of Fractionated Ster...   \n",
       "1538  Gastric Cancer Marker Detection and Its Kit De...   \n",
       "1692  HER2-low Unresectable and/or Metastatic Breast...   \n",
       "1693  Artificial Intelligence Analysis for Magnetic ...   \n",
       "1724  Safety of Continuing HER-2 Directed Therapy in...   \n",
       "1725  Cancer in Patients on Dapagliflozin and Other ...   \n",
       "1731  Real-world Clinical Benefit Evaluation in Brea...   \n",
       "1751  Savolitinib Combine With Durvalumab in EGFR Wi...   \n",
       "1784  DNA-Guided Second Line Adjuvant Therapy For Hi...   \n",
       "1793  Developing and Evaluating Culturally Relevant ...   \n",
       "1834  Effect of Intravenous S-ketamine on Opioid Con...   \n",
       "1982  Cross-sectional Case and Control Study on Qual...   \n",
       "2033  Tempus Priority Study: A Pan-tumor Observation...   \n",
       "2081  PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEA...   \n",
       "2108  68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor...   \n",
       "2137  Open Label, Multicenter, Real World Practice o...   \n",
       "2418  SYNERGY-AI: Artificial Intelligence Based Prec...   \n",
       "2464  Triple Negative Breast Cancer and Germline Her...   \n",
       "2537  Role of IMP3 Expression in Colorectal Carcinom...   \n",
       "2545  Targeted Therapy Directed by Genetic Testing i...   \n",
       "2609  HER2 Expression of CTC to Predict Response in ...   \n",
       "2616  LYNPARZA Breast Cancer in the Adjuvant Setting...   \n",
       "2618  Investigation of Ultrasound Imaging and Spectr...   \n",
       "2644  Photoacoustic Imaging for Characterizing Breas...   \n",
       "2691  Endocrine Response in Women With Invasive Lobu...   \n",
       "2794  Brass Mesh Bolus in Rotational Post-Mastectomy...   \n",
       "2985                Population-based Cancer Observatory   \n",
       "3242  Ultrasound Imaging, Spectroscopy and Ultrasoun...   \n",
       "3250  Supermicrosurgery for Breast Cancer Survivors ...   \n",
       "3314  Evaluation of the Acceptability, Appropriatene...   \n",
       "3328  Using Imaging Data and Genomic Data to Predict...   \n",
       "3370  DETERMINE Trial Treatment Arm 01: Alectinib in...   \n",
       "3512  Improving Patient-Centered Communication in Br...   \n",
       "3531  Breast Cancer Patient Engagement With Patient ...   \n",
       "3537  Case Control Study to Identify Modifiable Risk...   \n",
       "3665  Liquid-biopsy Informed Platform Trial to Evalu...   \n",
       "3822  Colonoscopy Screening: Setting Epic Follow-up ...   \n",
       "3834  HER2(Human Epidermal Growth Factor Receptor 2)...   \n",
       "\n",
       "                                             STUDY_URL STUDY_STATUS  \\\n",
       "35    https://www.clinicaltrials.gov/study/NCT05364138   Recruiting   \n",
       "115   https://www.clinicaltrials.gov/study/NCT05834686   Recruiting   \n",
       "132   https://www.clinicaltrials.gov/study/NCT05770544   Recruiting   \n",
       "227   https://www.clinicaltrials.gov/study/NCT05770102   Recruiting   \n",
       "242   https://www.clinicaltrials.gov/study/NCT05949021   Recruiting   \n",
       "296   https://www.clinicaltrials.gov/study/NCT05851677   Recruiting   \n",
       "426   https://www.clinicaltrials.gov/study/NCT04660435   Recruiting   \n",
       "436   https://www.clinicaltrials.gov/study/NCT05305092   Recruiting   \n",
       "546   https://www.clinicaltrials.gov/study/NCT04265937   Recruiting   \n",
       "724   https://www.clinicaltrials.gov/study/NCT03953157   Recruiting   \n",
       "868   https://www.clinicaltrials.gov/study/NCT05359120   Recruiting   \n",
       "1088  https://www.clinicaltrials.gov/study/NCT05614375   Recruiting   \n",
       "1108  https://www.clinicaltrials.gov/study/NCT00579514   Recruiting   \n",
       "1160  https://www.clinicaltrials.gov/study/NCT05463796   Recruiting   \n",
       "1173  https://www.clinicaltrials.gov/study/NCT04367779   Recruiting   \n",
       "1199  https://www.clinicaltrials.gov/study/NCT06223763   Recruiting   \n",
       "1204  https://www.clinicaltrials.gov/study/NCT03050268   Recruiting   \n",
       "1270  https://www.clinicaltrials.gov/study/NCT04428515   Recruiting   \n",
       "1326  https://www.clinicaltrials.gov/study/NCT00898131   Recruiting   \n",
       "1371  https://www.clinicaltrials.gov/study/NCT00196833   Recruiting   \n",
       "1380  https://www.clinicaltrials.gov/study/NCT04947280   Recruiting   \n",
       "1538  https://www.clinicaltrials.gov/study/NCT05010863   Recruiting   \n",
       "1692  https://www.clinicaltrials.gov/study/NCT05913440   Recruiting   \n",
       "1693  https://www.clinicaltrials.gov/study/NCT04996615   Recruiting   \n",
       "1724  https://www.clinicaltrials.gov/study/NCT04680442   Recruiting   \n",
       "1725  https://www.clinicaltrials.gov/study/NCT02695121   Recruiting   \n",
       "1731  https://www.clinicaltrials.gov/study/NCT05428527   Recruiting   \n",
       "1751  https://www.clinicaltrials.gov/study/NCT05374603   Recruiting   \n",
       "1784  https://www.clinicaltrials.gov/study/NCT04567420   Recruiting   \n",
       "1793  https://www.clinicaltrials.gov/study/NCT05665660   Recruiting   \n",
       "1834  https://www.clinicaltrials.gov/study/NCT05060068   Recruiting   \n",
       "1982  https://www.clinicaltrials.gov/study/NCT05932121   Recruiting   \n",
       "2033  https://www.clinicaltrials.gov/study/NCT05179824   Recruiting   \n",
       "2081  https://www.clinicaltrials.gov/study/NCT05769517   Recruiting   \n",
       "2108  https://www.clinicaltrials.gov/study/NCT05228106   Recruiting   \n",
       "2137  https://www.clinicaltrials.gov/study/NCT04068168   Recruiting   \n",
       "2418  https://www.clinicaltrials.gov/study/NCT03452774   Recruiting   \n",
       "2464  https://www.clinicaltrials.gov/study/NCT02302742   Recruiting   \n",
       "2537  https://www.clinicaltrials.gov/study/NCT05601388   Recruiting   \n",
       "2545  https://www.clinicaltrials.gov/study/NCT05564377   Recruiting   \n",
       "2609  https://www.clinicaltrials.gov/study/NCT05834699   Recruiting   \n",
       "2616  https://www.clinicaltrials.gov/study/NCT05677308   Recruiting   \n",
       "2618  https://www.clinicaltrials.gov/study/NCT04050423   Recruiting   \n",
       "2644  https://www.clinicaltrials.gov/study/NCT04428528   Recruiting   \n",
       "2691  https://www.clinicaltrials.gov/study/NCT02206984   Recruiting   \n",
       "2794  https://www.clinicaltrials.gov/study/NCT05483712   Recruiting   \n",
       "2985  https://www.clinicaltrials.gov/study/NCT03687151   Recruiting   \n",
       "3242  https://www.clinicaltrials.gov/study/NCT00437879   Recruiting   \n",
       "3250  https://www.clinicaltrials.gov/study/NCT03578380   Recruiting   \n",
       "3314  https://www.clinicaltrials.gov/study/NCT05440929   Recruiting   \n",
       "3328  https://www.clinicaltrials.gov/study/NCT03941639   Recruiting   \n",
       "3370  https://www.clinicaltrials.gov/study/NCT05770037   Recruiting   \n",
       "3512  https://www.clinicaltrials.gov/study/NCT04549571   Recruiting   \n",
       "3531  https://www.clinicaltrials.gov/study/NCT03995082   Recruiting   \n",
       "3537  https://www.clinicaltrials.gov/study/NCT05044689   Recruiting   \n",
       "3665  https://www.clinicaltrials.gov/study/NCT05601440   Recruiting   \n",
       "3822  https://www.clinicaltrials.gov/study/NCT05631873   Recruiting   \n",
       "3834  https://www.clinicaltrials.gov/study/NCT05905939   Recruiting   \n",
       "\n",
       "                                             CONDITIONS  \\\n",
       "35    Breast Cancer, Benign Breast Disease, Cervix C...   \n",
       "115                                       Breast Cancer   \n",
       "132   Solid Tumor, Haematological Malignancy, Malign...   \n",
       "227   Malignancy, Malignant Neoplasm, Lymphoprolifer...   \n",
       "242                Triple Negative Breast Cancer (TNBC)   \n",
       "296                                       Breast Cancer   \n",
       "426   Metastatic Breast Cancer, ER Positive Breast C...   \n",
       "436       Breast Cancer, Chemo-brain, Endocrine Therapy   \n",
       "546               Breast Cancer, Genetic Susceptibility   \n",
       "724   Anatomic Stage I Breast Cancer AJCC v8, Anatom...   \n",
       "868                                       Breast Cancer   \n",
       "1088  Sarcoma,Soft Tissue, Nasal Cavity Cancer, Para...   \n",
       "1108  Breast Cancer, Bladder Cancer, Kidney Cancer, ...   \n",
       "1160  Cancer Risk, Cancer Predisposition Syndrome, H...   \n",
       "1173                  Brain Cancer, Meningioma, Sarcoma   \n",
       "1199  Epithelial Ovarian Cancer, Fallopian Tube Neop...   \n",
       "1204  Acute Leukemia, Adenomatous Polyposis, Adrenoc...   \n",
       "1270                               Head and Neck Cancer   \n",
       "1326                                      Breast Cancer   \n",
       "1371                                      Breast Cancer   \n",
       "1380                     Bone Metastases, Breast Cancer   \n",
       "1538                                     Gastric Cancer   \n",
       "1692                                      Breast Cancer   \n",
       "1693          Breast Cancer, Magnetic Resonance Imaging   \n",
       "1724                       Breast Cancer, Heart Failure   \n",
       "1725                      Breast Cancer, Bladder Cancer   \n",
       "1731                             Cancer-related Fatigue   \n",
       "1751                                        Lung Cancer   \n",
       "1784                                      Breast Cancer   \n",
       "1793                                      Breast Cancer   \n",
       "1834                              Breast Cancer Surgery   \n",
       "1982        Papillary Thyroid Carcinoma, Thyroid Cancer   \n",
       "2033  Breast Cancer, Prostate Cancer, Bladder Cancer...   \n",
       "2081  BRCA Mutation, Ovarian Cancer, Ultrasound Ther...   \n",
       "2108                                      Solid Cancers   \n",
       "2137                                        Lung Cancer   \n",
       "2418  Cancer, Metastatic, Cancer, Cancer of Pancreas...   \n",
       "2464  Breast Cancer, Hereditary Breast and Ovarian C...   \n",
       "2537                                  Colorectal Cancer   \n",
       "2545  Advanced Malignant Solid Neoplasm, Anatomic St...   \n",
       "2609                                      Breast Cancer   \n",
       "2616                                      Breast Cancer   \n",
       "2618                                      Breast Cancer   \n",
       "2644                                      Breast Cancer   \n",
       "2691                                      Breast Cancer   \n",
       "2794                                      Breast Cancer   \n",
       "2985                                             Cancer   \n",
       "3242                             Breast Cancer Invasive   \n",
       "3250                Secondary Lymphedema, Breast Cancer   \n",
       "3314              Metastatic Breast Cancer, End of Life   \n",
       "3328                                      Breast Cancer   \n",
       "3370  Solid Tumor, Haematological Malignancy, Malign...   \n",
       "3512  Anatomic Stage 0 Breast Cancer AJCC v8, Anatom...   \n",
       "3531                                      Breast Cancer   \n",
       "3537                   Colorectal Cancer, Breast Cancer   \n",
       "3665                                      Breast Cancer   \n",
       "3822  Concordance Between Colonoscopy Follow up Inte...   \n",
       "3834                                      Breast Cancer   \n",
       "\n",
       "                                              LOCATIONS          START_DATE  \\\n",
       "35    [{'Location Facility': 'Partners in Health (In...       July 31, 2023   \n",
       "115   [{'Location Facility': 'The Fifth Medical Cent...     January 1, 2023   \n",
       "132   [{'Location Facility': 'Belfast City Hospital'...           June 2024   \n",
       "227   [{'Location Facility': 'Belfast City Hospital'...    October 25, 2023   \n",
       "242   [{'Location Facility': 'RWJBarnabas Health - T...     October 7, 2023   \n",
       "296   [{'Location Facility': 'Renji Hospital, School...        June 1, 2023   \n",
       "426   [{'Location Facility': 'Hospital Santo Stefano...   September 1, 2020   \n",
       "436   [{'Location Facility': 'Tangdu Hospital', 'Loc...        May 31, 2022   \n",
       "546   [{'Location Facility': 'Zhen Hu', 'Location Ci...        July 1, 2019   \n",
       "724   [{'Location Facility': 'UCLA / Jonsson Compreh...     October 7, 2019   \n",
       "868   [{'Location Facility': 'Henan cancer hospital'...        May 30, 2022   \n",
       "1088  [{'Location Facility': 'Yu Hongmeng', 'Locatio...       June 12, 2021   \n",
       "1108  [{'Location Facility': 'Memorial Sloan Ketteri...          March 2000   \n",
       "1160  [{'Location Facility': 'Dana Farber Cancer Ins...      April 25, 2023   \n",
       "1173  [{'Location Facility': 'Centre Léon Bérard', '...  September 24, 2020   \n",
       "1199  [{'Location Facility': 'Clínica Universidad de...     January 1, 2024   \n",
       "1204  [{'Location Facility': \"St. Jude Children's Re...       April 6, 2017   \n",
       "1270  [{'Location Facility': 'Sunnybrook Health Scie...      April 23, 2019   \n",
       "1326  [{'Location Facility': 'Robert H. Lurie Compre...         August 2001   \n",
       "1371  [{'Location Facility': 'German Breast Group', ...          April 2003   \n",
       "1380  [{'Location Facility': 'Fudan University Shang...     January 1, 2021   \n",
       "1538  [{'Location Facility': 'No. 109, Xueyuan West ...     January 1, 2021   \n",
       "1692  [{'Location Facility': 'Research Site', 'Locat...        May 30, 2023   \n",
       "1693  [{'Location Facility': \"Peking university peop...   September 1, 2021   \n",
       "1724  [{'Location Facility': 'Hospital de Clínicas d...        July 1, 2021   \n",
       "1725  [{'Location Facility': 'Research Site', 'Locat...     January 1, 2017   \n",
       "1731  [{'Location Facility': 'E-Da Cancer Hospital',...   September 8, 2021   \n",
       "1751  [{'Location Facility': 'Research Site', 'Locat...   November 23, 2022   \n",
       "1784  [{'Location Facility': 'University of Arizona ...    February 9, 2021   \n",
       "1793  [{'Location Facility': 'Center for Indigenous ...        June 6, 2023   \n",
       "1834  [{'Location Facility': 'Second Affiliated Hosp...     October 7, 2021   \n",
       "1982  [{'Location Facility': 'Department of General ...       June 25, 2023   \n",
       "2033  [{'Location Facility': 'Providence Medical Fou...    October 19, 2020   \n",
       "2081  [{'Location Facility': 'Fondazione Policlinico...      March 20, 2023   \n",
       "2108  [{'Location Facility': 'CHUS', 'Location City'...    January 21, 2022   \n",
       "2137  [{'Location Facility': 'Research Site', 'Locat...    January 30, 2020   \n",
       "2418  [{'Location Facility': 'Massive Bio, Inc', 'Lo...     January 1, 2018   \n",
       "2464  [{'Location Facility': 'Hays Medical Center Dr...      March 22, 2011   \n",
       "2537  [{'Location Facility': 'Faculty of Medicine', ...     October 1, 2022   \n",
       "2545  [{'Location Facility': 'University of Alabama ...       April 7, 2023   \n",
       "2609  [{'Location Facility': 'The Fifth Medical Cent...     January 1, 2023   \n",
       "2616  [{'Location Facility': 'Research Site', 'Locat...       March 7, 2023   \n",
       "2618  [{'Location Facility': 'Sunnybrook Health Scie...  September 23, 2014   \n",
       "2644  [{'Location Facility': 'Sunnybrook Health Scie...   February 13, 2017   \n",
       "2691  [{'Location Facility': 'UAB Comprehensive Canc...  September 30, 2015   \n",
       "2794  [{'Location Facility': 'Nova Scotia Health Aut...    January 18, 2023   \n",
       "2985  [{'Location Facility': 'Nice University Hospit...     January 1, 2005   \n",
       "3242  [{'Location Facility': 'Sunnybrook Health Scie...   December 17, 2008   \n",
       "3250  [{'Location Facility': 'Sykehuset Telemark', '...    January 26, 2016   \n",
       "3314  [{'Location Facility': 'University of North Ca...       July 15, 2022   \n",
       "3328  [{'Location Facility': 'The Chinese University...   September 1, 2019   \n",
       "3370  [{'Location Facility': 'Belfast City Hospital'...   December 18, 2023   \n",
       "3512  [{'Location Facility': 'Kaiser Permanente-Vall...    January 15, 2021   \n",
       "3531  [{'Location Facility': 'University of Colorado...    October 30, 2019   \n",
       "3537  [{'Location Facility': 'Obafemi Awolowo Univer...      April 12, 2021   \n",
       "3665  [{'Location Facility': 'BCCA - Cancer Centre f...       June 13, 2023   \n",
       "3822  [{'Location Facility': 'Massachusetts General ...   November 18, 2022   \n",
       "3834  [{'Location Facility': 'Research Site', 'Locat...        May 31, 2023   \n",
       "\n",
       "         COMPLETION_DATE                        AGE  \\\n",
       "35        March 30, 2024  ||Child|Adult|Older Adult   \n",
       "115           April 2025  ||Child|Adult|Older Adult   \n",
       "132         October 2029  ||Child|Adult|Older Adult   \n",
       "227         October 2029  ||Child|Adult|Older Adult   \n",
       "242   September 30, 2027  ||Child|Adult|Older Adult   \n",
       "296          August 2027  ||Child|Adult|Older Adult   \n",
       "426     December 1, 2026  ||Child|Adult|Older Adult   \n",
       "436         May 30, 2027  ||Child|Adult|Older Adult   \n",
       "546        June 30, 2026  ||Child|Adult|Older Adult   \n",
       "724         June 1, 2025  ||Child|Adult|Older Adult   \n",
       "868             May 2024  ||Child|Adult|Older Adult   \n",
       "1088       June 12, 2026  ||Child|Adult|Older Adult   \n",
       "1108          March 2024  ||Child|Adult|Older Adult   \n",
       "1160      March 25, 2032  ||Child|Adult|Older Adult   \n",
       "1173           June 2024  ||Child|Adult|Older Adult   \n",
       "1199        June 1, 2024  ||Child|Adult|Older Adult   \n",
       "1204      March 31, 2037  ||Child|Adult|Older Adult   \n",
       "1270      April 23, 2027  ||Child|Adult|Older Adult   \n",
       "1326        January 2025  ||Child|Adult|Older Adult   \n",
       "1371          April 2026  ||Child|Adult|Older Adult   \n",
       "1380   December 31, 2026  ||Child|Adult|Older Adult   \n",
       "1538   December 30, 2030  ||Child|Adult|Older Adult   \n",
       "1692        May 31, 2024  ||Child|Adult|Older Adult   \n",
       "1693  September 30, 2025  ||Child|Adult|Older Adult   \n",
       "1724    December 1, 2025  ||Child|Adult|Older Adult   \n",
       "1725   December 31, 2024  ||Child|Adult|Older Adult   \n",
       "1731   December 31, 2023  ||Child|Adult|Older Adult   \n",
       "1751   December 31, 2024  ||Child|Adult|Older Adult   \n",
       "1784   December 15, 2026  ||Child|Adult|Older Adult   \n",
       "1793       December 2025  ||Child|Adult|Older Adult   \n",
       "1834        July 7, 2024  ||Child|Adult|Older Adult   \n",
       "1982       July 31, 2024  ||Child|Adult|Older Adult   \n",
       "2033    October 19, 2030  ||Child|Adult|Older Adult   \n",
       "2081         May 2, 2026  ||Child|Adult|Older Adult   \n",
       "2108    January 31, 2027  ||Child|Adult|Older Adult   \n",
       "2137     August 31, 2024  ||Child|Adult|Older Adult   \n",
       "2418           June 2025  ||Child|Adult|Older Adult   \n",
       "2464       December 2025  ||Child|Adult|Older Adult   \n",
       "2537        June 1, 2023  ||Child|Adult|Older Adult   \n",
       "2545        July 1, 2030  ||Child|Adult|Older Adult   \n",
       "2609          April 2025  ||Child|Adult|Older Adult   \n",
       "2616   December 31, 2026  ||Child|Adult|Older Adult   \n",
       "2618      September 2029  ||Child|Adult|Older Adult   \n",
       "2644   February 13, 2029  ||Child|Adult|Older Adult   \n",
       "2691          March 2023  ||Child|Adult|Older Adult   \n",
       "2794   November 21, 2023  ||Child|Adult|Older Adult   \n",
       "2985   December 31, 2050  ||Child|Adult|Older Adult   \n",
       "3242           June 2029  ||Child|Adult|Older Adult   \n",
       "3250   December 31, 2024  ||Child|Adult|Older Adult   \n",
       "3314       July 15, 2025  ||Child|Adult|Older Adult   \n",
       "3328        June 1, 2025  ||Child|Adult|Older Adult   \n",
       "3370        October 2029  ||Child|Adult|Older Adult   \n",
       "3512        January 2027  ||Child|Adult|Older Adult   \n",
       "3531           June 2025  ||Child|Adult|Older Adult   \n",
       "3537          April 2024  ||Child|Adult|Older Adult   \n",
       "3665           June 2028  ||Child|Adult|Older Adult   \n",
       "3822       June 30, 2024  ||Child|Adult|Older Adult   \n",
       "3834        May 31, 2024  ||Child|Adult|Older Adult   \n",
       "\n",
       "                                   ELIGIBILITY_CRITERIA  \\\n",
       "35    Inclusion criteria include all individuals eva...   \n",
       "115   Eligibility includes individuals with patholog...   \n",
       "132   Eligibility includes adults, teenagers, and ch...   \n",
       "227   Participants must fulfill eligibility criteria...   \n",
       "242   Eligibility includes newly diagnosed early-sta...   \n",
       "296   Participants must have histologically confirme...   \n",
       "426   Women aged 18 or older with ER-positive, HER2-...   \n",
       "436   Inclusion criteria include premenopausal women...   \n",
       "546   Inclusion criteria include breast cancer patie...   \n",
       "724   Eligibility includes women diagnosed with loca...   \n",
       "868   Eligibility includes pathologically diagnosed ...   \n",
       "1088  Inclusion criteria include signing the informe...   \n",
       "1108  Eligibility includes patients with a histologi...   \n",
       "1160  Participants include those with hereditary can...   \n",
       "1173  Eligibility includes male or female patients o...   \n",
       "1199  Eligibility includes patients over 18 years ol...   \n",
       "1204  This study targets individuals with a history ...   \n",
       "1270  Eligibility includes individuals with histolog...   \n",
       "1326  Participants are eligible if they are undergoi...   \n",
       "1371  Women with histologically confirmed breast can...   \n",
       "1380  Eligibility includes individuals with invasive...   \n",
       "1538  Eligibility includes patients aged ≥18 years w...   \n",
       "1692  Eligibility includes patients with confirmed d...   \n",
       "1693  Eligibility includes patients undergoing full ...   \n",
       "1724  Participants must have Stage I-III HER-2 posit...   \n",
       "1725  Inclusion criteria include patients newly pres...   \n",
       "1731  Inclusion criteria include breast cancer patie...   \n",
       "1751  Eligibility includes patients 18 years or olde...   \n",
       "1784  Eligibility includes Stage II or III, HER2 neg...   \n",
       "1793  Eligibility includes women referred for screen...   \n",
       "1834  Eligibility includes female patients with an A...   \n",
       "1982  Inclusion criteria include PTC patients who un...   \n",
       "2033  Eligibility includes individuals with solid or...   \n",
       "2081  Participants must have available gBRCA1/2 test...   \n",
       "2108  Eligible participants include those with a cli...   \n",
       "2137  Inclusion criteria include patients eligible f...   \n",
       "2418  Eligibility includes patients with solid and h...   \n",
       "2464  Eligibility includes Triple Negative Breast Ca...   \n",
       "2537  Inclusion criteria include patients with color...   \n",
       "2545  Eligibility includes patients with measurable ...   \n",
       "2609  Eligibility includes individuals with patholog...   \n",
       "2616  Eligibility includes patients initiating treat...   \n",
       "2618  Eligibility includes both women and men with s...   \n",
       "2644  Eligibility includes men and women aged 20-80,...   \n",
       "2691  Eligibility includes women with histologically...   \n",
       "2794  Women undergoing rotational chest wall radioth...   \n",
       "2985  Inclusion criteria include all subjects diagno...   \n",
       "3242  Eligibility includes individuals with histolog...   \n",
       "3250  Participants are eligible if they have unilate...   \n",
       "3314  Participants must have verbal informed consent...   \n",
       "3328  Individuals are eligible if they have a clinic...   \n",
       "3370  Eligibility includes adults, teenagers, and ch...   \n",
       "3512  Eligibility includes women aged 21-84, newly d...   \n",
       "3531  The study targets adult females (18 years or o...   \n",
       "3537  For the case group, patients must have a histo...   \n",
       "3665  Eligibility includes adults (≥18 years) with h...   \n",
       "3822  Inclusion criteria focus on GI specialists at ...   \n",
       "3834  Eligibility includes patients with HER2-positi...   \n",
       "\n",
       "                                       PRIMARY_OUTCOMES  \\\n",
       "35    The primary outcome focuses on the number of p...   \n",
       "115   The primary outcome measure is Progression Fre...   \n",
       "132   The primary outcomes focus on Objective Respon...   \n",
       "227   The primary outcomes include Objective Respons...   \n",
       "242   The primary outcome is the Disease-Free Surviv...   \n",
       "296   The primary outcome measure is Progression-Fre...   \n",
       "426   The primary outcome measure is progression-fre...   \n",
       "436   The study measures changes in the brain's gray...   \n",
       "546   The primary outcome is to measure the frequenc...   \n",
       "724   Primary outcomes focus on bone mineral density...   \n",
       "868   The primary outcome measure is Time to Failure...   \n",
       "1088  The primary outcome measure is overall surviva...   \n",
       "1108  The primary outcome is to collect anonymized g...   \n",
       "1160  The primary outcome is to identify exposures, ...   \n",
       "1173  The primary outcome is to identify predictive ...   \n",
       "1199  The primary outcome measure is the comparison ...   \n",
       "1204  The primary outcome of the study is the identi...   \n",
       "1270  The primary outcome focuses on the correlation...   \n",
       "1326  The primary outcome is to collect human breast...   \n",
       "1371                                     Not specified.   \n",
       "1380  The primary outcome measure is the local contr...   \n",
       "1538  The primary outcome is to obtain subject serum...   \n",
       "1692  The study aims to assess the overall prevalenc...   \n",
       "1693  The primary outcome is to compare the rates of...   \n",
       "1724  The primary outcomes focus on the efficacy and...   \n",
       "1725  The primary outcomes focus on the incidence of...   \n",
       "1731  The primary outcome measure is the improvement...   \n",
       "1751  The primary outcome measure is Progression-Fre...   \n",
       "1784  The primary outcomes focus on two phases: the ...   \n",
       "1793  The primary outcome measure is the uptake of m...   \n",
       "1834  The primary outcome measure is the consumption...   \n",
       "1982  The primary outcome focuses on the cosmetic ou...   \n",
       "2033  The primary outcome is to create a robust data...   \n",
       "2081  The study aims to enhance and prospectively va...   \n",
       "2108  The primary outcome focuses on the incidence o...   \n",
       "2137  The primary outcomes focus on assessing the sa...   \n",
       "2418  The primary outcome measure is the proportion ...   \n",
       "2464  The primary outcomes include the prevalence of...   \n",
       "2537  The primary outcome is to evaluate the immunoh...   \n",
       "2545  Primary outcomes focus on the accrual, assignm...   \n",
       "2609  The primary outcome measure is Progression Fre...   \n",
       "2616  The primary outcome is to measure the incidenc...   \n",
       "2618  The primary outcome is to select the best quan...   \n",
       "2644  The primary outcome focuses on correlating tre...   \n",
       "2691  The primary outcome measure is the change in K...   \n",
       "2794  The primary outcome measure is the skin dose e...   \n",
       "2985  The primary outcome is the enumeration of each...   \n",
       "3242  The primary outcome involves correlating chang...   \n",
       "3250  The primary outcome measure is the volume of t...   \n",
       "3314  The primary outcomes focus on identifying key ...   \n",
       "3328  The primary outcome is the area under the rece...   \n",
       "3370  The primary outcomes are Objective Response (O...   \n",
       "3512  The primary outcome is patient knowledge about...   \n",
       "3531  The primary outcome is patient satisfaction wi...   \n",
       "3537  The primary outcomes include the development a...   \n",
       "3665  The primary outcomes focus on evaluating the i...   \n",
       "3822  The primary outcomes involve implementing a ne...   \n",
       "3834  The primary outcomes aim to describe the clini...   \n",
       "\n",
       "                                     SECONDARY_OUTCOMES  \\\n",
       "35    Secondary outcomes include analyzing the media...   \n",
       "115   Secondary outcomes include the Objective Respo...   \n",
       "132   Secondary outcomes include Duration of Respons...   \n",
       "227   Secondary outcomes encompass Duration of Respo...   \n",
       "242   Secondary outcomes focus on the safety and tox...   \n",
       "296   The secondary outcome focuses on the assessmen...   \n",
       "426   The secondary outcome measure is the clinical ...   \n",
       "436   Secondary outcomes focus on the change in conc...   \n",
       "546   Secondary outcomes, measured over 1 year, incl...   \n",
       "724                No secondary outcomes were provided.   \n",
       "868   Secondary outcomes include Progression-free su...   \n",
       "1088  Secondary outcomes include local recurrence-fr...   \n",
       "1108  The secondary outcome involves analyzing DNA s...   \n",
       "1160                No secondary outcomes are provided.   \n",
       "1173  Secondary outcomes include identifying predict...   \n",
       "1199  Secondary outcomes include comparing Progressi...   \n",
       "1204                                     Not specified.   \n",
       "1270  Secondary outcomes aim to correlate changes in...   \n",
       "1326                                     Not specified.   \n",
       "1371                                     Not specified.   \n",
       "1380  Secondary outcomes include evaluating pain con...   \n",
       "1538               No secondary outcomes are specified.   \n",
       "1692  Secondary objectives include describing diagno...   \n",
       "1693  Secondary outcomes involve comparing the sensi...   \n",
       "1724  The secondary outcome measures the composite o...   \n",
       "1725  The secondary outcome measures the incidence o...   \n",
       "1731  Secondary outcomes include the level of fatigu...   \n",
       "1751  Secondary outcomes include Objective Response ...   \n",
       "1784  Secondary outcomes include assessing the feasi...   \n",
       "1793               No secondary outcomes were provided.   \n",
       "1834  Secondary outcomes include postoperative pain ...   \n",
       "1982  Secondary outcomes include the evaluation of t...   \n",
       "2033  Secondary outcomes include documenting specifi...   \n",
       "2081                No secondary outcomes are provided.   \n",
       "2108  Secondary outcomes aim to generate clinical in...   \n",
       "2137  Secondary outcomes aim to evaluate the efficac...   \n",
       "2418  Secondary outcomes include the impact of CTE o...   \n",
       "2464               No secondary outcomes were provided.   \n",
       "2537               No secondary outcomes were provided.   \n",
       "2545  Secondary outcomes include the rate of positiv...   \n",
       "2609  Secondary outcomes include the Objective Respo...   \n",
       "2616               No secondary outcomes were provided.   \n",
       "2618  The secondary outcome focuses on correlating t...   \n",
       "2644  The secondary outcome aims to investigate if b...   \n",
       "2691  Secondary outcomes include measuring estrogen ...   \n",
       "2794               No secondary outcomes were provided.   \n",
       "2985               No secondary outcomes are specified.   \n",
       "3242  Secondary outcomes focus on examining changes ...   \n",
       "3250  The secondary outcome is the health-related qu...   \n",
       "3314  Secondary outcomes aim to identify key barrier...   \n",
       "3328                                     Not specified.   \n",
       "3370  Secondary outcomes include Duration of Respons...   \n",
       "3512  Secondary outcomes include patient self-effica...   \n",
       "3531  Secondary outcomes include various BREAST Q Pa...   \n",
       "3537               No secondary outcomes were provided.   \n",
       "3665  Secondary outcomes include assessing the numbe...   \n",
       "3822               No secondary outcomes were provided.   \n",
       "3834  Secondary outcomes focus on describing diagnos...   \n",
       "\n",
       "                                          INTERVENTIONS  \\\n",
       "35    The document does not specify interventions di...   \n",
       "115   The intervention involves detecting HER2 expre...   \n",
       "132   The intervention involves administering entrec...   \n",
       "227   The intervention involves administering atezol...   \n",
       "242   The intervention involves a combination of lip...   \n",
       "296   The intervention involves administering the dr...   \n",
       "426   The intervention involves a diagnostic test ca...   \n",
       "436   Participants undergo PET/MRI scans, complete p...   \n",
       "546   The document does not specify interventions, s...   \n",
       "724   The study involves two experimental arms. Arm ...   \n",
       "868   Interventions involve patients in three cohort...   \n",
       "1088  The intervention involves patients with soft t...   \n",
       "1108  The intervention involves the PCR/PCR/LDR Stra...   \n",
       "1160  Participants across different risk groups (her...   \n",
       "1173  The study involves pediatric and adult patient...   \n",
       "1199  Interventions involve cytoreductive surgery ai...   \n",
       "1204                                     Not specified.   \n",
       "1270  The intervention involves the use of a Photoac...   \n",
       "1326                                     Not specified.   \n",
       "1371                                     Not specified.   \n",
       "1380  The intervention involves participants being p...   \n",
       "1538  The intervention involves blood collection fro...   \n",
       "1692  The document does not specify interventions, s...   \n",
       "1693  The intervention involves women at high risk o...   \n",
       "1724  The study involves two groups: a control group...   \n",
       "1725  The document does not specify interventions, s...   \n",
       "1731  The intervention involves breast cancer patien...   \n",
       "1751  The intervention involves a combination of two...   \n",
       "1784  The study involves two arms: Arm A (experiment...   \n",
       "1793  The study involves two experimental arms. The ...   \n",
       "1834  The study involves three arms: a placebo group...   \n",
       "1982  The study involves two groups of PTC patients ...   \n",
       "2033  The study involves two groups, both under the ...   \n",
       "2081  The intervention involves conducting a multice...   \n",
       "2108  The intervention involves an intravenous injec...   \n",
       "2137  The document does not provide specific details...   \n",
       "2418  The intervention involves Clinical Trial Match...   \n",
       "2464  The study does not involve any interventions a...   \n",
       "2537                   No interventions were specified.   \n",
       "2545  Interventions vary across multiple experimenta...   \n",
       "2609  The intervention involves detecting HER2 expre...   \n",
       "2616           No specific interventions were detailed.   \n",
       "2618  The document does not specify interventions, s...   \n",
       "2644  The study involves two arms using the Photoaco...   \n",
       "2691  The study involves three active comparator arm...   \n",
       "2794  The intervention involves patients undergoing ...   \n",
       "2985  The study involves an observational interventi...   \n",
       "3242  The document does not specify interventions di...   \n",
       "3250  The study involves two arms: the experimental ...   \n",
       "3314  The intervention involves conducting semi-stru...   \n",
       "3328                                     Not specified.   \n",
       "3370  The intervention involves administering alecti...   \n",
       "3512  Interventions involve patients using the iCanD...   \n",
       "3531  Participants in the experimental group will re...   \n",
       "3537  The study involves two main interventions acro...   \n",
       "3665  The study involves three experimental arms: Su...   \n",
       "3822  The intervention consists of a research assist...   \n",
       "3834  The study does not specify interventions, as i...   \n",
       "\n",
       "                                       POINT_OF_CONTACT  \\\n",
       "35    {'Name': None, 'Organization': None, 'Email': ...   \n",
       "115   {'Name': None, 'Organization': None, 'Email': ...   \n",
       "132   {'Name': None, 'Organization': None, 'Email': ...   \n",
       "227   {'Name': None, 'Organization': None, 'Email': ...   \n",
       "242   {'Name': None, 'Organization': None, 'Email': ...   \n",
       "296   {'Name': None, 'Organization': None, 'Email': ...   \n",
       "426   {'Name': None, 'Organization': None, 'Email': ...   \n",
       "436   {'Name': None, 'Organization': None, 'Email': ...   \n",
       "546   {'Name': None, 'Organization': None, 'Email': ...   \n",
       "724   {'Name': None, 'Organization': None, 'Email': ...   \n",
       "868   {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1088  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1108  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1160  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1173  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1199  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1204  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1270  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1326  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1371  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1380  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1538  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1692  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1693  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1724  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1725  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1731  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1751  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1784  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1793  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1834  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1982  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2033  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2081  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2108  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2137  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2418  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2464  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2537  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2545  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2609  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2616  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2618  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2644  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2691  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2794  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2985  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3242  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3250  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3314  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3328  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3370  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3512  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3531  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3537  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3665  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3822  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3834  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "\n",
       "                  formatted_age  \n",
       "35    ||Child|Adult|Older Adult  \n",
       "115   ||Child|Adult|Older Adult  \n",
       "132   ||Child|Adult|Older Adult  \n",
       "227   ||Child|Adult|Older Adult  \n",
       "242   ||Child|Adult|Older Adult  \n",
       "296   ||Child|Adult|Older Adult  \n",
       "426   ||Child|Adult|Older Adult  \n",
       "436   ||Child|Adult|Older Adult  \n",
       "546   ||Child|Adult|Older Adult  \n",
       "724   ||Child|Adult|Older Adult  \n",
       "868   ||Child|Adult|Older Adult  \n",
       "1088  ||Child|Adult|Older Adult  \n",
       "1108  ||Child|Adult|Older Adult  \n",
       "1160  ||Child|Adult|Older Adult  \n",
       "1173  ||Child|Adult|Older Adult  \n",
       "1199  ||Child|Adult|Older Adult  \n",
       "1204  ||Child|Adult|Older Adult  \n",
       "1270  ||Child|Adult|Older Adult  \n",
       "1326  ||Child|Adult|Older Adult  \n",
       "1371  ||Child|Adult|Older Adult  \n",
       "1380  ||Child|Adult|Older Adult  \n",
       "1538  ||Child|Adult|Older Adult  \n",
       "1692  ||Child|Adult|Older Adult  \n",
       "1693  ||Child|Adult|Older Adult  \n",
       "1724  ||Child|Adult|Older Adult  \n",
       "1725  ||Child|Adult|Older Adult  \n",
       "1731  ||Child|Adult|Older Adult  \n",
       "1751  ||Child|Adult|Older Adult  \n",
       "1784  ||Child|Adult|Older Adult  \n",
       "1793  ||Child|Adult|Older Adult  \n",
       "1834  ||Child|Adult|Older Adult  \n",
       "1982  ||Child|Adult|Older Adult  \n",
       "2033  ||Child|Adult|Older Adult  \n",
       "2081  ||Child|Adult|Older Adult  \n",
       "2108  ||Child|Adult|Older Adult  \n",
       "2137  ||Child|Adult|Older Adult  \n",
       "2418  ||Child|Adult|Older Adult  \n",
       "2464  ||Child|Adult|Older Adult  \n",
       "2537  ||Child|Adult|Older Adult  \n",
       "2545  ||Child|Adult|Older Adult  \n",
       "2609  ||Child|Adult|Older Adult  \n",
       "2616  ||Child|Adult|Older Adult  \n",
       "2618  ||Child|Adult|Older Adult  \n",
       "2644  ||Child|Adult|Older Adult  \n",
       "2691  ||Child|Adult|Older Adult  \n",
       "2794  ||Child|Adult|Older Adult  \n",
       "2985  ||Child|Adult|Older Adult  \n",
       "3242  ||Child|Adult|Older Adult  \n",
       "3250  ||Child|Adult|Older Adult  \n",
       "3314  ||Child|Adult|Older Adult  \n",
       "3328  ||Child|Adult|Older Adult  \n",
       "3370  ||Child|Adult|Older Adult  \n",
       "3512  ||Child|Adult|Older Adult  \n",
       "3531  ||Child|Adult|Older Adult  \n",
       "3537  ||Child|Adult|Older Adult  \n",
       "3665  ||Child|Adult|Older Adult  \n",
       "3822  ||Child|Adult|Older Adult  \n",
       "3834  ||Child|Adult|Older Adult  "
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['AGE'].apply(has_numerical_age) == False]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>NCT_NUMBER</th>\n",
       "      <th>STUDY_TITLE</th>\n",
       "      <th>STUDY_URL</th>\n",
       "      <th>STUDY_STATUS</th>\n",
       "      <th>CONDITIONS</th>\n",
       "      <th>LOCATIONS</th>\n",
       "      <th>START_DATE</th>\n",
       "      <th>COMPLETION_DATE</th>\n",
       "      <th>AGE</th>\n",
       "      <th>ELIGIBILITY_CRITERIA</th>\n",
       "      <th>PRIMARY_OUTCOMES</th>\n",
       "      <th>SECONDARY_OUTCOMES</th>\n",
       "      <th>INTERVENTIONS</th>\n",
       "      <th>POINT_OF_CONTACT</th>\n",
       "      <th>formatted_age</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>NCT05664971</td>\n",
       "      <td>JS004 Combined With Toripalimab and With Stand...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05664971</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Advanced Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'Shanghai Chest Hospita...</td>\n",
       "      <td>February 9, 2023</td>\n",
       "      <td>November 17, 2024</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligible participants include males or females...</td>\n",
       "      <td>The primary outcomes include the incidence of ...</td>\n",
       "      <td>Secondary outcomes encompass the duration of r...</td>\n",
       "      <td>The study involves multiple cohorts receiving ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>18 years</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT05902520</td>\n",
       "      <td>Adoptive Cell Therapy Using Cancer Specific CD...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05902520</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>HNSCC, Melanoma, Gynecologic Cancer, Colorecta...</td>\n",
       "      <td>[{'Location Facility': 'Providence Portland Me...</td>\n",
       "      <td>June 19, 2023</td>\n",
       "      <td>May 19, 2026</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes adults over 18 with histo...</td>\n",
       "      <td>The primary outcome is to assess the safety of...</td>\n",
       "      <td>Secondary outcomes include evaluating the effi...</td>\n",
       "      <td>The study involves two experimental arms. Both...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>18 years</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT03917043</td>\n",
       "      <td>APG-2449 in Patients With Advanced Solid Tumors</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03917043</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Advanced Solid Cancer, Non Small Cell Lung Can...</td>\n",
       "      <td>[{'Location Facility': 'Beijing Cancer Hospita...</td>\n",
       "      <td>May 27, 2019</td>\n",
       "      <td>February 2025</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with advanced tu...</td>\n",
       "      <td>The primary outcomes are to determine the maxi...</td>\n",
       "      <td>Secondary outcomes include measuring the maxim...</td>\n",
       "      <td>The intervention involves administering APG-24...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>18 years</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT05674422</td>\n",
       "      <td>GEMCAD-REVEAL STUDY - Circulating Tumor DNA as...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05674422</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Patients With Locally Advanced Rectal Cancer</td>\n",
       "      <td>[{'Location Facility': 'Hospital Germans Trias...</td>\n",
       "      <td>May 26, 2023</td>\n",
       "      <td>July 2026</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligible participants are legally capable indi...</td>\n",
       "      <td>The primary outcome measure is the detection o...</td>\n",
       "      <td>Secondary outcomes include the classification ...</td>\n",
       "      <td>The intervention involves total neoadjuvant th...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>18 years</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT06249854</td>\n",
       "      <td>Efficacy and Safety of Combination Therapy Wit...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT06249854</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Non-small Cell Lung Cancer</td>\n",
       "      <td>[{'Location Facility': 'Korea University Ansan...</td>\n",
       "      <td>February 8, 2024</td>\n",
       "      <td>December 31, 2025</td>\n",
       "      <td>19 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes adults aged 19 or older w...</td>\n",
       "      <td>The primary outcome measure is Progression-Fre...</td>\n",
       "      <td>Secondary outcomes include Disease Control Rat...</td>\n",
       "      <td>The study involves two groups: one receiving P...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>19 years</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3831</th>\n",
       "      <td>3831</td>\n",
       "      <td>NCT05006131</td>\n",
       "      <td>Pancreatic Cancer Screening for At-risk Indivi...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05006131</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Pancreatic Cancer, Adult</td>\n",
       "      <td>[{'Location Facility': 'Beth Israel Deaconess ...</td>\n",
       "      <td>July 10, 2020</td>\n",
       "      <td>July 10, 2026</td>\n",
       "      <td>18 Years|90 Years|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes individuals indicated for...</td>\n",
       "      <td>The primary outcome is the proportion of scree...</td>\n",
       "      <td>Secondary outcomes include the proportion of s...</td>\n",
       "      <td>The intervention involves screening for pancre...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>18 years | 90 years</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3832</th>\n",
       "      <td>3832</td>\n",
       "      <td>NCT04679064</td>\n",
       "      <td>Trial on NIraparib-TSR-042 (Dostarlimab) vs Ph...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04679064</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Ovarian Cancer</td>\n",
       "      <td>[{'Location Facility': 'Azienda Ospedaliera Sp...</td>\n",
       "      <td>December 1, 2020</td>\n",
       "      <td>January 1, 2025</td>\n",
       "      <td>18 Years||Adult|Older Adult</td>\n",
       "      <td>Eligibility includes recurrent ovarian, Fallop...</td>\n",
       "      <td>The primary outcome measure is overall surviva...</td>\n",
       "      <td>Secondary outcomes include progression-free su...</td>\n",
       "      <td>Interventions include a choice of standard che...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>18 years</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3833</th>\n",
       "      <td>3833</td>\n",
       "      <td>NCT04491864</td>\n",
       "      <td>DWIBS-MRI: An Adjunct to the Traditional Diagn...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT04491864</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Baylor Scott &amp; White R...</td>\n",
       "      <td>March 11, 2019</td>\n",
       "      <td>March 11, 2024</td>\n",
       "      <td>30 Years||Adult|Older Adult</td>\n",
       "      <td>Eligible participants are genetic females over...</td>\n",
       "      <td>The study aims to assess the accuracy of MRI D...</td>\n",
       "      <td>No secondary outcomes were provided.</td>\n",
       "      <td>The document does not specify interventions, f...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>30 years</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3834</th>\n",
       "      <td>3834</td>\n",
       "      <td>NCT05905939</td>\n",
       "      <td>HER2(Human Epidermal Growth Factor Receptor 2)...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT05905939</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[{'Location Facility': 'Research Site', 'Locat...</td>\n",
       "      <td>May 31, 2023</td>\n",
       "      <td>May 31, 2024</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "      <td>Eligibility includes patients with HER2-positi...</td>\n",
       "      <td>The primary outcomes aim to describe the clini...</td>\n",
       "      <td>Secondary outcomes focus on describing diagnos...</td>\n",
       "      <td>The study does not specify interventions, as i...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>||Child|Adult|Older Adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3835</th>\n",
       "      <td>3835</td>\n",
       "      <td>NCT03934905</td>\n",
       "      <td>Protective Effects of the Nutritional Suppleme...</td>\n",
       "      <td>https://www.clinicaltrials.gov/study/NCT03934905</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Anthracycline Related Cardiotoxicity in Breast...</td>\n",
       "      <td>[{'Location Facility': 'Texas Tech University ...</td>\n",
       "      <td>June 1, 2022</td>\n",
       "      <td>June 1, 2026</td>\n",
       "      <td>18 Years|89 Years|Adult|Older Adult</td>\n",
       "      <td>Participants aged 18 to 89, without prior diag...</td>\n",
       "      <td>The primary outcome is the change in cardiac f...</td>\n",
       "      <td>Secondary outcomes include monitoring troponin...</td>\n",
       "      <td>Participants will receive either sulforaphane ...</td>\n",
       "      <td>{'Name': None, 'Organization': None, 'Email': ...</td>\n",
       "      <td>18 years | 89 years</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3836 rows × 16 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0   NCT_NUMBER  \\\n",
       "0              0  NCT05664971   \n",
       "1              1  NCT05902520   \n",
       "2              2  NCT03917043   \n",
       "3              3  NCT05674422   \n",
       "4              4  NCT06249854   \n",
       "...          ...          ...   \n",
       "3831        3831  NCT05006131   \n",
       "3832        3832  NCT04679064   \n",
       "3833        3833  NCT04491864   \n",
       "3834        3834  NCT05905939   \n",
       "3835        3835  NCT03934905   \n",
       "\n",
       "                                            STUDY_TITLE  \\\n",
       "0     JS004 Combined With Toripalimab and With Stand...   \n",
       "1     Adoptive Cell Therapy Using Cancer Specific CD...   \n",
       "2       APG-2449 in Patients With Advanced Solid Tumors   \n",
       "3     GEMCAD-REVEAL STUDY - Circulating Tumor DNA as...   \n",
       "4     Efficacy and Safety of Combination Therapy Wit...   \n",
       "...                                                 ...   \n",
       "3831  Pancreatic Cancer Screening for At-risk Indivi...   \n",
       "3832  Trial on NIraparib-TSR-042 (Dostarlimab) vs Ph...   \n",
       "3833  DWIBS-MRI: An Adjunct to the Traditional Diagn...   \n",
       "3834  HER2(Human Epidermal Growth Factor Receptor 2)...   \n",
       "3835  Protective Effects of the Nutritional Suppleme...   \n",
       "\n",
       "                                             STUDY_URL STUDY_STATUS  \\\n",
       "0     https://www.clinicaltrials.gov/study/NCT05664971   Recruiting   \n",
       "1     https://www.clinicaltrials.gov/study/NCT05902520   Recruiting   \n",
       "2     https://www.clinicaltrials.gov/study/NCT03917043   Recruiting   \n",
       "3     https://www.clinicaltrials.gov/study/NCT05674422   Recruiting   \n",
       "4     https://www.clinicaltrials.gov/study/NCT06249854   Recruiting   \n",
       "...                                                ...          ...   \n",
       "3831  https://www.clinicaltrials.gov/study/NCT05006131   Recruiting   \n",
       "3832  https://www.clinicaltrials.gov/study/NCT04679064   Recruiting   \n",
       "3833  https://www.clinicaltrials.gov/study/NCT04491864   Recruiting   \n",
       "3834  https://www.clinicaltrials.gov/study/NCT05905939   Recruiting   \n",
       "3835  https://www.clinicaltrials.gov/study/NCT03934905   Recruiting   \n",
       "\n",
       "                                             CONDITIONS  \\\n",
       "0                                  Advanced Lung Cancer   \n",
       "1     HNSCC, Melanoma, Gynecologic Cancer, Colorecta...   \n",
       "2     Advanced Solid Cancer, Non Small Cell Lung Can...   \n",
       "3          Patients With Locally Advanced Rectal Cancer   \n",
       "4                            Non-small Cell Lung Cancer   \n",
       "...                                                 ...   \n",
       "3831                           Pancreatic Cancer, Adult   \n",
       "3832                                     Ovarian Cancer   \n",
       "3833                                      Breast Cancer   \n",
       "3834                                      Breast Cancer   \n",
       "3835  Anthracycline Related Cardiotoxicity in Breast...   \n",
       "\n",
       "                                              LOCATIONS        START_DATE  \\\n",
       "0     [{'Location Facility': 'Shanghai Chest Hospita...  February 9, 2023   \n",
       "1     [{'Location Facility': 'Providence Portland Me...     June 19, 2023   \n",
       "2     [{'Location Facility': 'Beijing Cancer Hospita...      May 27, 2019   \n",
       "3     [{'Location Facility': 'Hospital Germans Trias...      May 26, 2023   \n",
       "4     [{'Location Facility': 'Korea University Ansan...  February 8, 2024   \n",
       "...                                                 ...               ...   \n",
       "3831  [{'Location Facility': 'Beth Israel Deaconess ...     July 10, 2020   \n",
       "3832  [{'Location Facility': 'Azienda Ospedaliera Sp...  December 1, 2020   \n",
       "3833  [{'Location Facility': 'Baylor Scott & White R...    March 11, 2019   \n",
       "3834  [{'Location Facility': 'Research Site', 'Locat...      May 31, 2023   \n",
       "3835  [{'Location Facility': 'Texas Tech University ...      June 1, 2022   \n",
       "\n",
       "        COMPLETION_DATE                                  AGE  \\\n",
       "0     November 17, 2024          18 Years||Adult|Older Adult   \n",
       "1          May 19, 2026          18 Years||Adult|Older Adult   \n",
       "2         February 2025          18 Years||Adult|Older Adult   \n",
       "3             July 2026          18 Years||Adult|Older Adult   \n",
       "4     December 31, 2025          19 Years||Adult|Older Adult   \n",
       "...                 ...                                  ...   \n",
       "3831      July 10, 2026  18 Years|90 Years|Adult|Older Adult   \n",
       "3832    January 1, 2025          18 Years||Adult|Older Adult   \n",
       "3833     March 11, 2024          30 Years||Adult|Older Adult   \n",
       "3834       May 31, 2024            ||Child|Adult|Older Adult   \n",
       "3835       June 1, 2026  18 Years|89 Years|Adult|Older Adult   \n",
       "\n",
       "                                   ELIGIBILITY_CRITERIA  \\\n",
       "0     Eligible participants include males or females...   \n",
       "1     Eligibility includes adults over 18 with histo...   \n",
       "2     Eligibility includes patients with advanced tu...   \n",
       "3     Eligible participants are legally capable indi...   \n",
       "4     Eligibility includes adults aged 19 or older w...   \n",
       "...                                                 ...   \n",
       "3831  Eligibility includes individuals indicated for...   \n",
       "3832  Eligibility includes recurrent ovarian, Fallop...   \n",
       "3833  Eligible participants are genetic females over...   \n",
       "3834  Eligibility includes patients with HER2-positi...   \n",
       "3835  Participants aged 18 to 89, without prior diag...   \n",
       "\n",
       "                                       PRIMARY_OUTCOMES  \\\n",
       "0     The primary outcomes include the incidence of ...   \n",
       "1     The primary outcome is to assess the safety of...   \n",
       "2     The primary outcomes are to determine the maxi...   \n",
       "3     The primary outcome measure is the detection o...   \n",
       "4     The primary outcome measure is Progression-Fre...   \n",
       "...                                                 ...   \n",
       "3831  The primary outcome is the proportion of scree...   \n",
       "3832  The primary outcome measure is overall surviva...   \n",
       "3833  The study aims to assess the accuracy of MRI D...   \n",
       "3834  The primary outcomes aim to describe the clini...   \n",
       "3835  The primary outcome is the change in cardiac f...   \n",
       "\n",
       "                                     SECONDARY_OUTCOMES  \\\n",
       "0     Secondary outcomes encompass the duration of r...   \n",
       "1     Secondary outcomes include evaluating the effi...   \n",
       "2     Secondary outcomes include measuring the maxim...   \n",
       "3     Secondary outcomes include the classification ...   \n",
       "4     Secondary outcomes include Disease Control Rat...   \n",
       "...                                                 ...   \n",
       "3831  Secondary outcomes include the proportion of s...   \n",
       "3832  Secondary outcomes include progression-free su...   \n",
       "3833               No secondary outcomes were provided.   \n",
       "3834  Secondary outcomes focus on describing diagnos...   \n",
       "3835  Secondary outcomes include monitoring troponin...   \n",
       "\n",
       "                                          INTERVENTIONS  \\\n",
       "0     The study involves multiple cohorts receiving ...   \n",
       "1     The study involves two experimental arms. Both...   \n",
       "2     The intervention involves administering APG-24...   \n",
       "3     The intervention involves total neoadjuvant th...   \n",
       "4     The study involves two groups: one receiving P...   \n",
       "...                                                 ...   \n",
       "3831  The intervention involves screening for pancre...   \n",
       "3832  Interventions include a choice of standard che...   \n",
       "3833  The document does not specify interventions, f...   \n",
       "3834  The study does not specify interventions, as i...   \n",
       "3835  Participants will receive either sulforaphane ...   \n",
       "\n",
       "                                       POINT_OF_CONTACT  \\\n",
       "0     {'Name': None, 'Organization': None, 'Email': ...   \n",
       "1     {'Name': None, 'Organization': None, 'Email': ...   \n",
       "2     {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3     {'Name': None, 'Organization': None, 'Email': ...   \n",
       "4     {'Name': None, 'Organization': None, 'Email': ...   \n",
       "...                                                 ...   \n",
       "3831  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3832  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3833  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3834  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "3835  {'Name': None, 'Organization': None, 'Email': ...   \n",
       "\n",
       "                  formatted_age  \n",
       "0                      18 years  \n",
       "1                      18 years  \n",
       "2                      18 years  \n",
       "3                      18 years  \n",
       "4                      19 years  \n",
       "...                         ...  \n",
       "3831        18 years | 90 years  \n",
       "3832                   18 years  \n",
       "3833                   30 years  \n",
       "3834  ||Child|Adult|Older Adult  \n",
       "3835        18 years | 89 years  \n",
       "\n",
       "[3836 rows x 16 columns]"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "def filter_by_age(age_input):\n",
    "        output = {\"age_min\" : \"age\",\n",
    "          \"age_max\" : \"age\" }\n",
    "        system_prompt = f\"\"\"You are helpful assistant to max age and min age from given senetence and give output in json format as {output} \"\"\" \n",
    "\n",
    "        response = openai.chat.completions.create(\n",
    "            model='gpt-4-0125-preview', \n",
    "            temperature=0,\n",
    "            messages=[\n",
    "                {\"role\":\"system\", \"content\":system_prompt},\n",
    "                {\"role\":\"user\", \"content\":f\"\"\" Extract the max age and min age from given input 18 Years|75 Years|Adult|Older Adult and give output in {output} format. \"\"\"},\n",
    "                {\"role\":\"assistant\", \"content\":\"\"\"{\"age_min\" : \"18\",\n",
    "          \"age_max\" : \"75\" }\"\"\" },\n",
    "          {\"role\":\"user\", \"content\":f\"\"\" Extract the max age and min age from given input {age_input} and give output in {output} format. \"\"\"},\n",
    "            ],\n",
    "            max_tokens = 1024,\n",
    "            response_format={ \"type\": \"json_object\" }\n",
    "            \n",
    "        )  \n",
    "        res = response.choices[0].message.content\n",
    "        return res"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [],
   "source": [
    "df[\"formatted_age\"] = df[\"AGE\"].apply(filter_by_age)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "output = {\"age_min\" : \"age\",\n",
    "          \"age_max\" : \"age\" }\n",
    "system_prompt = f\"\"\"You are helpful assistant to max age and min age from given senetence and give output in json format as {output} \"\"\"        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "age_input = df[\"AGE\"][6]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "response = openai.chat.completions.create(\n",
    "            model='gpt-4-0125-preview', \n",
    "            temperature=0,\n",
    "            messages=[\n",
    "                {\"role\":\"system\", \"content\":system_prompt},\n",
    "                {\"role\":\"user\", \"content\":f\"\"\" Extract the max age and min age from given input 18 Years|75 Years|Adult|Older Adult and give output in {output} format. \"\"\"},\n",
    "                {\"role\":\"assistant\", \"content\":\"\"\"{\"age_min\" : \"18\",\n",
    "          \"age_max\" : \"75\" }\"\"\" },\n",
    "          {\"role\":\"user\", \"content\":f\"\"\" Extract the max age and min age from given input {age_input} and give output in {output} format. \"\"\"},\n",
    "            ],\n",
    "            max_tokens = 1024,\n",
    "            response_format={ \"type\": \"json_object\" }\n",
    "            \n",
    "        )\n",
    "      "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'{\"age_min\": \"18\", \"age_max\": \"75\"}'"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response.choices[0].message.content"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
